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ABSTRACT 
 
 Evidence suggests comorbidity of ADHD and eating disorders (EDs) among females. 
Capitalizing on the comorbidity of ADHD and EDs and subsequent obesity could lead to 
improved prevention and treatment of all three conditions. However, additional information 
regarding the comorbidity is necessary to develop such interventions, as little is known about 
how or why this co-occurrence exists. A comprehensive model of the underlying mechanisms 
associated with comorbid ADHD and EDs is needed to improve understanding of the 
development of the comorbidity. Moreover, while there are gender differences within each 
disorder, literature is limited regarding to the comorbidity among males, leading to a call for 
further investigation. 
Based on the literature, this study investigated three hypotheses of the underlying 
mechanisms of the ADHD/ED comorbidity, including: 1) ADHD and EDs are the expression of a 
common genetic or neurobiological dysfunction that manifests itself as binge eating and ADHD, 
2) psychosocial factors common to both EDs and ADHD mediate the association between the 
two conditions, and 3) a third underlying mental health condition mediates the relationship 
between the two conditions. Underlying factors proposed within these three hypotheses include 
dopamine, serotonin, and monoamine oxidase A genes, family support, social support, 
neuroticism, conscientiousness, cognitive control, working memory, major depression, anxiety 
disorder, alcohol use and substance use disorders, and childhood abuse. 
In order to simultaneously investigate the three hypotheses, this study utilized secondary 
data analysis from 6,289 females and 5,248 males as part of the National Longitudinal Study of 
Adolescent Health. This data was used to test a model constructed via a combination of five 
 vi 
theories, specifically, the Biopsychosocial Model, the Life Course Approach, the Risk Regulator 
Framework, the Research Domain Criteria Matrix, and the Person-Environment Transaction 
Theory. 
  Findings of this study suggest that cognitive control, family support, and additional 
comorbid mental health illnesses such as depression, anxiety, and substance abuse disorder all 
mediate the relationship between ADHD and EDs. However, rather than leading to the 
comorbidity, ADHD led to other mental health issues which were then subsequently correlated 
to EDs; suggesting a comorbidity between these additional disorders and EDs with ADHD being 
a possible predictor of that comorbidity. In regards to genetics, the factors investigated in this 
study were not found to be directly associated with the comorbidity. Rather, these factors were 
connected to the psychosocial and psychiatric mediators, suggesting an indirect relationship 
between genetics and the comorbidity. With regards to males, differences were found between 
males with the comorbidity, ADHD alone, EDs alone, and neither disorder in regards to 
education attainment, BMI and obesity, delinquent behavior, and sexual behaviors were all 
observed. However, very few of the proposed underlying mechanisms among females were 
significantly associated with the comorbidity among males. 
  Results provide initial support for continued research on the underlying mechanisms of 
the ADHD/ ED comorbidity. This research has potential implications in many areas including 
primary and secondary prevention of EDs, improved treatment plans, prevention of 
psychostimulant medication abuse, and prevention and treatment of obesity. Next steps include 
the use of advanced statistical techniques in order to explore multiple combinations of 
underlying factors to the comorbidity and direct interactions between factors, including gene x 
environment interactions. Additional study replications are also needed with the incorporation of 
additional genetic components. 
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CHAPTER ONE: INTRODUCTION 
 
 The main goals of public health include preventing disease, promoting health, and 
prolonging the lifespan for the population at large (American Public Health Association [APHA], 
n.d.; World Health Organization, n.d.). Public health professionals aim to prevent health 
problems through health education and promotion, political action, and research (Centers for 
Disease Control and Prevention [CDC], n.d.). While traditional perspectives of public health may 
focus on physical conditions, such as vaccinations and environmental safety (CDC, n.d.), there 
is a growing recognition that complex public health issues are heavily influenced by behavioral 
health (Mabry, Olster, Morgan, & Abrams, 2008). The single-cause, single-disciplinary approach 
to health is no longer sufficient for handling complex, chronic diseases (Mabry et al., 2008). 
 Components of behavioral health, including substance abuse, tobacco use, and mental 
illness are among the leading predictors for the top chronic diseases in the United States (CDC, 
2005, 2011). In general, people with serious mental illness die earlier than the general 
population (Nardone, Snyder, & Paradise, 2014). Subsequently, it is crucial to incorporate 
behavioral health into any public health intervention. Similarly, prevention and management of 
behavioral health conditions could be improved by the addition of aspects of the public health 
system including surveillance, monitoring, and health promotion. This type of integrated and 
holistic approach is especially beneficial for addressing issues related to co-occurring mental 
and physical health disorders. 
While there are fundamental differences between public and behavioral health, each has 
a significant impact on the other. Despite the interplay of the two, behavioral health and public 
health systems are typically segregated, leading to a fragmented healthcare system (Nardone et 
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al., 2014). The fragmentation leads to inappropriate, redundant, and increased healthcare 
expenditures (Nardone et al., 2014). For example, just one-third of all Americans with mental 
health problems receive mental health treatment (Cunningham, 2009), leading to additional 
physical health issues, poor functioning, and increased healthcare spending among patients 
with complex comorbid conditions (Kathol, Butler, McAlpine, & Kane, 2010). Reducing the 
burden of, and ultimately preventing the most complex and chronic health problems, will require 
an understanding of the full range of determinants including biological, environmental, social, 
and behavioral mechanisms (Mabry et al., 2008). 
This need for integration holds especially true for children with co-occurring conditions.  
Children with mental health disorders are at high risk for many preventable physical health 
diseases (Bazelon, n.d.). These co-occurring disorders have significant financial and emotional 
implications for the entire family (Busch & Barry, 2007). While it is generally accepted that 
physical and mental health disorders interact, rather than integrated with physical health care, 
mental health services are typically viewed as additional or secondary services (Kathol et al., 
2010). Access to mental health care including screenings and treatment is crucial for children, 
as half of all serious mental illnesses begin by age fourteen (National Alliance on Mental Illness, 
2013). Despite the need for mental health services, half of children with a mental health 
condition go without care (National Alliance on Mental Illness, 2013) and less than 10% of those 
receiving mental health care continue treatment for more than three months (Behrens, Lear, & 
Price, 2013). In general, getting treatment for a child’s physical health condition is easier than 
for a psychological condition (Behrens et al., 2013). 
 
The Role of Behavioral Health in Public Health 
 Among the main tasks of public health is the prevention of death, disease, and disability 
(APHA, n.d.; World Health Organization, n.d.). Addressing issues associated with mental health 
is a key component for preventing disease as mental disorders are a leading cause of 
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premature death and account for approximately 25% of all disability (CDC, 2005; Nardone et al., 
2014). For example, depression is a key risk factor for many physical health conditions including 
cardiovascular disease and diabetes (CDC, 2005, 2011), and positive mental health is 
associated with better endocrine functioning and immune response (CDC, 2011). Behavioral 
health is also a predictor of overall wellbeing as many of the risk factors of the most common 
causes of death and disease are behavioral, including substance abuse, tobacco use, and 
alcohol consumption (Glanz & Bishop, 2010). Moreover, behavioral health influences many risk 
behaviors associated with chronic diseases including nutrition and physical inactivity (CDC, 
2005). Although the burden of mental illness as well as the connection between physical and 
mental health is widely recognized, mental health is not often included in public health 
campaigns and interventions (Bazelon Center for Mental Health Law, n.d.). 
Among children and adolescents, the integration of public and mental health could allow 
for early detection and treatment of chronic and debilitating conditions. As it is well recognized 
that behavioral health factors can lead to physical health issues, behavioral healthcare settings 
can be used as a delivery mechanism for physical health screenings. This could be extremely 
beneficial for the long-term trajectory of children with co-occurring physical and mental health 
conditions. As previously stated, the majority of mental illness begins in childhood and 
adolescence (National Alliance on Mental Illness, 2013), and is associated with subsequent 
physical health issues (CDC, 2005, 2011). Early intervention among this subset of children 
would address the main goals of public health by reducing chronic disease burden and 
disability. Subsequently, integrated public health and mental health prevention could have 
significant impacts on healthcare spending. Healthcare cost is a major concern for public health 
and as behavioral health related issues lead to significant healthcare costs, targeting behavioral 
health for prevention and improved treatment efforts can help reduce the financial burden on the 
overall healthcare system. 
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The Role of Public Health in Behavioral Health 
Excluding the costs of research, mental health issues costs the United States an 
estimated $150 billion annually (CDC, 2005). Public health can play a key role in behavioral 
health by reducing this financial burden though surveillance, screening, and prevention. The 
public health approach could include monitoring, assessment, prevention research, community 
education, health promotion, policy development, and systems change (CDC, 2011). Public 
health can provide support to behavioral health through community education, as public health 
has a long track record of success with community education and raising awareness (Bazelon 
Center for Mental Health Law, n.d.). Providing education and information related to accessing 
services could have significant impacts on prevention and treatment in behavioral health. As an 
example, a recent initiative from the Centers for Disease Control and Prevention has been 
successful at raising recognition of attention deficit disorder, a common childhood disorder with 
implications for several life domains (Bazelon Center for Mental Health Law, n.d.). 
Secondary prevention, or early detection, can help reduce the consequences of both 
physical and mental health conditions. For example, early detection of eating disorders can 
increase the likelihood of long-term recovery, as delays in treatment are associated with 
prolonged illness, poor prognosis, and relapse (Agras, 2001; Cavanaugh & Lemberg, 1999; 
Mitchell, 1995; National Eating Disorder Association, n.d.; Thompson & Smolak, 2001; 
Thompson & Smolak, 2001). While public health agencies have been working with pediatricians 
and primary care providers to develop behavioral health screening tools for at-risk children 
(Bazelon Center for Mental Health Law, n.d.), there are many barriers to referrals for mental 
health providers (Kathol et al., 2010). These barriers lead to a need for improved referral 
systems and integration of care. 
Between a half and two-thirds of Americans with mental health conditions are treated in 
primary care settings (CDC, 2011; Kathol et al., 2010). While access to mental health services 
is often considered a barrier to quality care (Cunningham, 2009), the shortage of mental health 
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providers has led to issues of access (Cunningham, 2009). Primary care providers (PCPs) are 
often used as referral mechanisms for other specialties; however, PCPs report that referrals to 
mental health specialists are twice as difficult to accomplish than any other specialty 
(Cunningham, 2009; Kathol et al., 2010). Moreover, even when a mental health specialist is 
available for a referral, long waits for an appointment, ranging from weeks to months, leads to 
poor outcomes for both physical and mental health conditions and increases service use and 
cost (Kathol et al., 2010). Without improvements in available mental health care services, an 
estimated $130 to $350 billion will be spent annually for additional service use among patients 
with co-occurring physical and mental health disorders (Kathol et al., 2010). 
 The lack of available mental health treatment options is exacerbated in the children’s 
healthcare system. As opposed to physical health services, mental health care for children is 
underdeveloped and less cohesive (Behrens et al., 2013). Pediatricians are more likely than any 
other PCPs to report issues related to mental health referrals (Cunningham, 2009). Specifically, 
pediatricians are 15% more likely to cite a shortage of providers as a barrier to referrals for 
outpatient mental health services (Cunningham, 2009). The integration of behavioral and public 
health could help to address this barrier. 
 
Integration of Behavioral and Public Health 
There is recent widespread recognition of potential positive implications of integrating 
public and behavioral health (CDC, 2011). This integration could be essential to overall health 
during a time of limited resources as system integration could be more effective than individual 
stakeholder efforts (CDC, 2011). Integrated care and research focuses on a holistic approach to 
health through the recognition of the complex and interacting components of the body and mind 
as a whole (Nardone et al., 2014). 
 In 1999, the Surgeon General released a report calling for the full integration of mental 
health into the nation’s public health system (CDC, 2011). Despite previous legislation aimed at 
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parity between physical and mental healthcare insurance coverage, including the Mental Health 
Parity Act of 1996 and the Mental Health Parity and Addiction Equity Act of 2008 (Centers for 
Medicare and Medicaid Services, n.d.), barriers to integration still persist. Integration would 
require increased coordination and cooperation among local, state, and federal agencies 
(Bazelon Center for Mental Health Law, n.d.), as well as significant effort from healthcare 
providers to adopt a holistic approach (Nardone et al., 2014). This adoption may be difficult as 
healthcare professions may view integrated approaches as overwhelming due to the additional 
time and follow-up needed for screening and referrals (Nardone et al., 2014). 
 
Application of Integration to Comorbid ADHD/ ED 
 The benefits of integrated public and behavioral health could apply to many physical and 
mental health comorbidities. One such example is the co-occurrence of ADHD, eating disorders 
(EDs), and subsequent obesity. Evidence has established a link between ADHD, EDs, and 
subsequent obesity (Cortese et al., 2008; Cortese, Bernardina, & Mouren, 2007; Davis, Levitan, 
Smith, Tweed, & Curtis, 2006). Beyond evidence related to the prevalence of this comorbidity, it 
has also been found that binge eating and loss of control eating mediate the relationship 
between ADHD and obesity (Reinblatt et al., 2015), and there may be a severity link between all 
three (Irving & Neumark-Sztainer, 2002). Integrating public and behavioral health could 
significantly improve the quality of life for children and adolescents with comorbid ADHD/ EDs. 
This can be achieved through the utilization of public health prevention techniques applied to 
mental illness as well as through the development of integrated mental and physical health care 
treatment teams. 
While there have been some effective school based ED primary prevention efforts, in 
general there are still major gaps. Among the gaps are prevention to address the needs of both 
genders, early detection efforts, and programs that address a broad spectrum of weight-related 
problems (Ciao, Loth, & Neumark-Sztainer, 2014). Similarly, although EDs are mental health 
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conditions with physical health consequences, and obesity is a physical health condition with 
mental health consequences, the conceptual similarities, shared risk factors, high correlation, 
and diagnostic crossover rates have led to a call for the promotion of healthy weight related 
programs as opposed to separate obesity and ED preventions (Irving & Neumark-Sztainer, 
2002). As the comorbidity exists for both genders and is associated with subsequent obesity, 
targeting children and adolescents with ADHD for primary prevention could allow for efforts to 
address current gaps in prevention. 
Utilizing public health prevention techniques and integrating physical and mental health 
into singular ED and obesity programs targeted at children and adolescents with ADHD could 
reduce program development and management costs (Irving & Neumark-Sztainer, 2002). 
Additionally, dual benefits of media literacy education and the use of social cognitive theory for 
prevention of both disorders have been proposed as justification for integrated prevention (Irving 
& Neumark-Sztainer, 2002). However, it was also noted that there are many barriers to this 
integration in that professionals from the two fields might not agree on the types of messages or 
content of an integrated model. Significant collaboration and open communication between 
mental health and physical health care providers would be needed to overcome this barrier 
(Irving & Neumark-Sztainer, 2002). 
In regards to secondary prevention, ADHD typically manifests in childhood (American 
Psychiatric Association [APA], 2013), while the average age of onset of EDs ranges from 
adolescents to early adulthood (Hudson, Hiripi, Pope Jr, & Kessler, 2007; Swanson, Crow, Le 
Grange, Swendsen, & Merikangas, 2011). Based on this trajectory, secondary prevention 
aspects of public health, including screening, behavior monitoring, and early referral can be 
utilized among children with ADHD to prevent EDs and subsequent obesity. Although evidence 
of comorbidity, due to limited training, the majority of pediatric healthcare providers (90%) report 
low levels of self-competence with regard to assessment and treatment of EDs in children and 
adolescents (Girz, Robinson, & Tessier, 2014; Robinson, Boachie, & Lafrance, 2013). 
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Improvements to medical curriculum regarding this comorbidity, behavioral health screening, 
and public health secondary prevention tools could provide the necessary conditions for 
appropriate monitoring and prevention of the development of the comorbidity. 
For treatment or tertiary prevention, it is important to note that EDs are most commonly 
treated by mental health professionals (Hay, 2013; Smolak & Thompson, 2009; Stein, Latzer, & 
Merick, 2009), while ADHD is primarily assessed and treated by PCPs (Rader, McCauley, & 
Callen, 2009). This fragmentation may contribute to the burden of the comorbidity and lead to 
increased health care utilization and spending. The promotion of care integration through team-
based models (i.e., health homes, accountable care organizations) in which patient specific 
treatment plans are developed in collaboration between the PCP and mental health care 
provider could significantly improve treatment success for the subset of patients with both 
disorders. These holistic approaches could allow for children and adolescents with comorbid 
ADHD and ED to receive the proper treatment needed for both disorders. 
 
Problem Statement 
 The burden associated with the comorbidity of ADHD and EDs and subsequent obesity 
could be significantly improved through the integration of primary and mental healthcare as well 
as public and behavioral health. Through coordinated care and improved training, this 
comorbidity allows for improved screening, prevention, and treatment of all three conditions. 
However, additional information regarding this comorbidity is necessary to develop such 
interventions. While there is evidence related to the existence of the comorbidity, little is known 
about how or why this co-occurrence exists. 
A comprehensive model of the underlying mechanisms associated with comorbid ADHD 
and EDs is needed to improve understanding of the development of the comorbidity. This model 
could then lead to the development of screening tools to help identify the subset of patients at-
risk for developing the comorbidity. Once identified as at-risk, this subset could be targeted for 
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prevention efforts and patient-specific treatment plans; ultimately preventing the comorbidity, 
associated obesity, and other physical health consequences. 
The improvement of secondary prevention via education and monitoring of adolescents 
at-risk for comorbid ADHD and EDs could also help address the Healthy People 2020 objective 
of reducing the prevalence of disordered eating behaviors in adolescents (U.S. Department of 
Health and Human Services, 2012). Concomitantly, a better understanding of the development 
of the comorbidity can be used to improve training and continued education among physicians 
who treat ADHD. In order to establish the evidence needed for future integrated prevention and 
care efforts, the current study aims to increase understanding of the underlying mechanisms of 
the ADHD/ED comorbidity.  
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CHAPTER TWO: LITERATURE REVIEW 
 
“Comorbidity between psychological disorders is often the rule rather than the exception” 
(Bobadilla, Vaske, & Asberg, 2013, p. 2555) 
 
Attention-deficit/hyperactivity disorder (ADHD) and eating disorders (EDs) are both 
significant public health concerns due to their prevalence, impact on physical and mental health, 
and associated academic and social impairment (Hudson et al., 2007; Ingram, Hechtman, & 
Morgenstern, 1999; National Institute of Mental Health, 2008; Polanczyk & Rohde, 2007; 
Swanson et al., 2011; Wade, Keski-Rahkonen, & Hudson, 2011; Wilfley, Wilson, & Agras, 2003; 
Willcutt, 2012). While each is separately associated with consequences for overall well being, 
evidence suggests that these two disorders co-occur (Cortese et al., 2007; Nazar et al., 2008), 
potentially leading to increased risk for negative outcomes throughout the life course. 
 
Epidemiology of ADHD 
ADHD is a neurobiological disorder categorized by inattention, hyperactivity, and 
impulsivity (APA, 2000, 2013; Rohde, Verin, & Polanczyk, 2012); however, it has not always 
been known as ADHD (Lange, Reichl, Lange, Tucha, & Tucha, 2010). In 1968, hyperkinetic 
reaction of childhood, described by overactivity, restlessness, distractibility, and short attention 
span, was added to the second edition of the diagnostic and statistical manual of mental 
disorders (DSM)(Lange et al., 2010). In the 1970s, focus shifted from hyperactivity to inattention 
and ultimately DSM III (1980) renamed the disorder attention deficit disorder (ADD) with or 
without hyperactivity (Lange et al., 2010). DSM III also established age of onset and duration 
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requirements as well as the minimum symptom cut-off needed for a diagnosis (APA, 1978; 
Lange et al., 2010). 
Based on the lack of information in regards to the sub-types of the disorder (i.e., with or 
without hyperactivity), the DSM-III-R (1987) renamed the disorder attention deficit-hyperactivity 
disorder and listed all symptoms in one category (Lange et al., 2010). Increasing evidence in the 
early 1990s suggested differences in symptomology, impairment, and outcomes between 
children with inattentive symptoms compared to children with hyperactive symptoms (Barkley, 
2005; Lange et al., 2010). This evidence led to the reinstatement of sub-types in the DSM IV 
(1994), specifically inattentive, hyperactive/impulsive, and combined sub-types (APA, 2000; 
Lange et al., 2010). 
The release of the 2013 DSM V made several additional changes to the diagnostic 
criteria of ADHD based on the most current data on the disorder. To account for the fact that 
impairing symptoms persist in adulthood in up to 65% of cases, DSM V added information and 
criteria related to adult ADHD (APA, 2013; Faraone, Biederman, & Mick, 2006). Moreover, the 
age of onset criteria was changed from a required symptom onset prior to age seven (APA, 
2000) to the increased age twelve (APA, 2013). Lastly, sub-types were replaced with 
predominant presentations based on evidence suggesting that children often shift between the 
sub-types over time, with most childhood hyperactive/ impulsive cases being re-diagnosed as 
combined by school age (APA, 2000, 2013; Lahey, Applegate, McBurnett, & Biederman, 1994). 
Current criteria state that a diagnosis of ADHD requires the presence of six or more symptoms 
from either or both the inattentive or hyperactive/ impulsive symptom categories occurring often 
for at least six months (APA, 2013). These symptoms must cause impairment in at least two 
settings, such as work, school, or home, and have clear evidence of interference with 
appropriate social, academic, or occupational functioning (APA, 2013). 
ADHD is one of the most common childhood disorders in the United States, and 
prevalence has steadily increased over the past decade (Visser et al., 2014). Based on data 
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from the 2011 National Survey of Children’s Health, the prevalence of parent-reported ADHD 
diagnoses among children four to seventeen years old has continuously increased from 7.8% in 
2003, to 9.5% in 2007, and most recently to 11% in 2011 (Visser et al., 2014). Diagnostic rates 
are higher in males than females (15.1% vs. 6.7% in 2011) (Visser et al., 2014). However, 
prevalence of ADHD among females has been observed at higher rates in community samples 
as opposed to clinical samples, potentially suggesting gender-based diagnostic and treatment 
disparities (Polanczyk & Rohde, 2007; Rohde et al., 2012). 
Prevalence of diagnosed ADHD also differs by race and socioeconomic status. 
Specifically, prevalence is higher among African American and Caucasian children (twice as 
high compared to Hispanic children), children living in English speaking households (four times 
increased likelihood), and children from higher educated households (Visser et al., 2014). 
However, children living in households 200% below the federal poverty line have higher rates of 
diagnosed ADHD compared to children from high-income families (Visser et al., 2014). These 
differences may not be true socio-demographic differences but rather the result of disparities in 
healthcare insurance coverage, as children with health insurance have higher rates of 
diagnosed ADHD (Visser et al., 2014). Moreover rates are higher among those with public 
health insurance compared to private coverage. In 2011, 14.4% of children with public 
healthcare coverage had ever been diagnosed with ADHD (Visser et al., 2014). 
Prevalence of diagnosed ADHD may be heavily influenced by health care coverage 
(Visser et al., 2014), diagnostic methodology (i.e. parent, teacher, and/ or child reported 
symptomology) (Polanczyk & Rohde, 2007), and the vagueness in diagnostic criteria. Since 
DSM III, diagnostic criteria required symptoms to be often and impairing, but the DSM does not 
define either term (APA, 1978, 2000, 2013). As attention span naturally varies in children, 
determining frequency and severity may be highly subjective (Buitelaar & Rothenberger, 2004; 
Polanczyk & Rohde, 2007). 
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Associated academic and social impairment has been observed in both children with 
and without formal ADHD diagnoses (Ingram et al., 1999; Loe & Feldman, 2007), thus it is 
necessary to investigate prevalence of ADHD symptoms or behaviors (i.e., sub-clinical) as well 
as diagnoses. A 2012 meta-analysis reported that using parent ratings only, 6.1% of children 
and adolescents met full criteria, while 8.8% met symptom only criteria. Similarly, with teacher 
ratings 7.1% met full criteria and 13.3% met symptoms only criteria. Lastly, based on self-report, 
8.5% of children and adolescents met symptom criteria (Willcutt, 2012). Investigations of socio-
demographic differences in symptomology have been inconsistent with some studies finding 
signficant differences by race, socioeconomic status, and urbanicity, and others finding no 
differences (Angold et al., 2002; Kessler et al., 2005; Polanczyk & Rohde, 2007). 
At both the clinical and sub-clinical level, ADHD is associated with decreased self-
esteem, lack of financial independence, and academic and interpersonal impairment (Ingram et 
al., 1999; Loe & Feldman, 2007; Rohde et al., 2012). Impairment persists into adulthood, 
resulting in reduced quality of life, increased healthcare need, and associated healthcare costs 
(Eaton et al., 2010). The economic impact of ADHD in the United States is estimated at an 
annual incremental cost of $143 to $266 billion per year (Doshi et al., 2012). ADHD is rarely 
observed alone and is highly comorbid with other mental illnesses (Hill, 2012). Common 
psychiatric comorbidities include oppositional-defiant disorder, conduct disorder, antisocial 
personality disorder, developmental disorders, autism spectrum disorders, Tourette syndrome, 
bipolar disorder, depression, anxiety, substance abuse, and addictions (Biederman et al., 2006; 
Hill, 2012; Polanczyk & Rohde, 2007). 
 
Epidemiology of Eating Disorders 
 Eating disorder is an umbrella term for a group of disorders described by persistent 
disturbances in eating or weight related behaviors; these disorders including Anorexia Nervosa 
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(AN), Bulimia Nervosa (BN), Binge Eating Disorder (BED), and Eating Disorder Not Otherwise 
Specified (EDNOS) (APA, 2013). 
AN is characterized by distorted body image, excessive dieting, severe weight loss, and 
a fear of weight gain (APA, 2013). Prior DSM IV criteria requiring amenorrhea, or the absence of 
at least three menstrual cycles, was removed from the recent DSM V to account for people that 
this criteria could not apply to such as males, pre-menarche females, and females taking oral 
contraceptives (APA, 2000, 2013). BN is characterized by episodes of binge eating, which 
entails eating a larger than normal amount of food in a discrete period of time and a sense of 
lack of control over eating, followed by inappropriate compensatory behaviors such as self-
induced vomiting, fasting, excessive exercise, or misuse of laxatives, diuretics, or other 
medications (APA, 2013). For a DSM V diagnosis, these behaviors must occur on average once 
a week for three months (APA, 2013; Wilfley, Bishop, Wilson, & Agras, 2007); a decrease from 
the twice weekly required in DSM IV (APA, 2000, 2013). 
BED was added to the appendix of the DSM IV and listed as a disorder requiring further 
study (APA, 2013). It was subsequently added as an ED sub-type in DSM V (APA, 2013). Thus 
until the DSM V, anyone with BED would have been diagnosed with the EDNOS, as BED was 
not officially diagnosable. BED is characterized as binge eating without compensatory behaviors 
on average at least once a week over three months (APA, 2013; Wilfley et al., 2007). BED is 
often associated with obesity, however level of psychopathology, weight and shape concerns, 
and quality of life differ between obese individuals with BED and obese individuals without BED 
(Wonderlich, Gordon, Mitchell, Crosby, & Engel, 2009). Lastly, EDNOS is a catch-all term of any 
cases that do not meet full criteria for a specific ED (APA, 2013), for example someone who 
does not meet frequency criteria for BN or BED, or low weight criteria for AN. Based on DSM IV 
criteria, 60% of cases were considered EDNOS (Fairburn & Bohn, 2005). The changes in the 
DSM V, especially the addition of BED to the ED category, were made specifically to minimize 
the use of EDNOS (APA, 2013). 
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Although recent diagnostic changes help decrease the overuse of EDNOS, there are still 
several concerns with the diagnostic criteria. While EDs are diagnostically mutually exclusive 
disorders (APA, 2013), the core symptoms of all EDs are similar, including preoccupation with 
food and weight, and body dissatisfaction (Polivy & Herman, 2002). Moreover, despite the 
mutual exclusiveness, similar to ADHD sub-types, ED diagnoses are generally not stable over 
time (Fairburn & Cooper, 2011). People often change between restrictive, binging, and purging 
behaviors throughout the course of their disorder (Fairburn & Cooper, 2011). As a result, 
diagnoses are often considered “snapshots” of current behaviors as opposed to an indicator of a 
specific disorder (Fairburn & Cooper, 2011). For example, one study found that over a 30-month 
period, only a third of 192 women with an ED retained diagnostic criteria for the same ED 
(Milos, Spindler, Schnyder, & Fairburn, 2005). Similarly, a group of 216 women diagnosed with 
either AN or BN were followed via weekly ED symptom assessments over seven years. Nearly 
75% of women with diagnosed AN experienced diagnostic crossover towards BN, with 
crossover most commonly occurring during a progression towards recovery. However, women 
with a BN diagnosis were unlikely to experience crossover to AN (Eddy et al., 2008). 
Prevalence of EDs has generally increased over the past four decades (Hudson et al., 
2007; Striegel-Moore & Franko, 2003; Tenore, 2001; Wade et al., 2011). Specifically, incidence 
rates of BN in women age ten to thirty-nine tripled between 1988 and 1993 (Hoek & van 
Hoeken, 2003), and AN incidence in women age fifteen to nineteen has continually increased in 
every decade since 1930 (Hoek & van Hoeken, 2003). Estimates suggest that the lifetime 
prevalence ranges from 0.5% to 1.0% for AN, 0.5% to 3.0% for BN, and 1.6% to 5.3% for BED 
(Striegel-Moore & Franko, 2003; Swanson et al., 2011). AN and BN rates are typically higher 
among females, while BED has been observed to be more prevalence among males (Hudson et 
al., 2007; Striegel-Moore & Franko, 2003; Swanson et al., 2011). Among adolescent boys, 6% 
report regular binge eating and 8.3% report regular episodes of loss of control eating (Mond et 
al., 2014). 
 16 
Estimates from the 2001-2003 National Comorbidity Survey Replication suggest that the 
median age of onset of each type of ED ranges from eighteen to twenty-one years old, with 
onset of 18.9 years old for AN, 19.7 years old for BN, and 25.4 years old for BED (Hudson et al., 
2007). However, estimates from the 2001-2004 adolescent supplement of the National 
Comorbidity Study Replication suggests much younger onset, with estimates of 12.3 years old 
for AN, 12.4 years old for BN, and 12.6 years old for BED (Swanson et al., 2011). 
Comparatively, results from a longitudinal investigation of a large community sample reported 
peak onset for BN and BED between seventeen and eighteen years old (Stice, Marti, Shaw, & 
Jaconis, 2009). 
EDs are chronic and persistent. Years of disorder duration is much longer for disorders 
associated with binge eating with average disorder durations of 1.7 years for AN, 8.3 years for 
BN, and 8.1 years for BED (Hudson et al., 2007). Similarly, just slightly over half of all ED cases 
fully recover after 10-years and approximately one third of all patients relapse after recovery 
(Agras, 2001; Herzog et al., 1999; Steinhausen, 2009). Results from a longitudinal investigation 
with a community sample reported relapse rates of 41% for BN and 33% for BED (Stice et al., 
2009). 
EDs have the highest mortality rate of all mental illnesses (Arcelus, Mitchell, Wales, & 
Nielsen, 2011; Sullivan, 1995). Using random-effects meta-analysis, a recent study reported a 
5.86 deaths per 1,000 person-years standardized mortality ratio (SMR) for AN (Arcelus et al., 
2011). The SMR for BN was 1.93 deaths per 1,000 person-years, and 1.92 deaths per 1,000 
person-years for EDNOS (Arcelus et al., 2011). A large portion of these deaths was due to 
suicide, with one in five deaths among AN patients due to suicide (Arcelus et al., 2011). Based 
on the studies reviewed, it was determined that factors that influenced mortality included older 
age and low body mass index at first presentation, alcohol misuse, and comorbid mental 
illnesses (Arcelus et al., 2011). More than half of all cases present with at least one comorbid 
condition, which most commonly were mood, anxiety, impulsive control, substance abuse, or 
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bipolar disorders (Hudson et al., 2007; McElroy, Kotwal, Keck Jr, & Akiskal, 2005). Comorbid 
psychiatric conditions are associated with a threefold increase in the risk of death among AN 
patients (Papadopoulos, Ekbom, Brandt, & Ekselius, 2009). 
 Beyond increased mortality, EDs are associated with long-term physical and mental 
health consequences (Haines & Neumark-Sztainer, 2006; National Eating Disorder Association 
(n.d.); Neumark-Sztainer et al., 2006; Neumark-Sztainer et al., 2007). Some of these 
consequences include cardiovascular damage, osteoporosis, kidney failure, ulcers, anxiety, 
depression, and alcohol and substance abuse (Fairburn & Harrison, 2003; Haines & Neumark-
Sztainer, 2006; National Eating Disorder Association (n.d.); Neumark-Sztainer & Hannan, 2000; 
Neumark-Sztainer et al., 2006; Neumark-Sztainer et al., 2007). EDs are also associated with 
social and familial impairment. Additionally, AN is associated with severe social impairment, and 
BN and BED are associated with both social and family impairment (Swanson et al., 2011).  
 Disordered eating behaviors, including EDNOS, are cases of ED behaviors that do not 
meet full diagnostic criteria. However, these behaviors are still associated with severe health 
consequences, evident by the similar SMR rates between patients with BN and EDNOS 
(Arcelus et al., 2011). Cases of EDNOS or sub-clinical EDs often progress to clinical EDs, and 
patients with EDNOS have similar physical health consequences as patients with full diagnostic 
criteria (Neumark-Sztainer, 2003; Peebles, Hardy, Wilson, & Lock, 2010). EDNOS patients 
typically have similar psychological profiles to those who meet full criteria for AN and BN as well 
as the same outcomes in terms of heart rate, blood pressure, temperature, and QTc interval 
(Peebles et al., 2010). 
Current estimates suggest that up to ten million males and twenty million females in the 
United States present with some form of disordered eating behavior (National Association of 
Anorexia Nervosa and Associated Disorders, n.d.). More specifically, 14% of all adolescents 
and 31% adult females engage in disordered eating behaviors (Reba-Harrelson et al., 2009; 
U.S. Department of Health and Human Services, 2012). One study conducted diagnostic 
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interviews among a large community sample of adoelscent girls over eight years. Lifetime 
prevalence rates by age twenty were 0.6% for AN for both diagnosable cases and sub-clinical 
level behaviors; however, while 1.6% and 1.0% of the sample met criteria for BN and BED 
respectively, 6.1% and 4.6% had subthreshold behaviors of each disorder. A total of 12% of the 
sample had some form of ED behavior (Stice et al., 2009). While many sub-clinical cases 
progressed to diagnosable disorders, sub-clinical BN and BED are associated with significant 
impairment and distress (Stice et al., 2009). The prevalence and potential health consequences 
of EDNOS, or sub-clinical EDs, has resulted in the addition of a new Healthy People 2020 
objective, which aims to reduce the proportion of adolescents who engage in disordered eating 
behaviors in an attempt to control their weight (U.S. Department of Health and Human Services, 
2012). 
 
Epidemiology of Comorbid ADHD/ ED 
 Evidence demonstrates comorbidity between ADHD and EDs with the majority of studies 
focusing on females. It was reported that worldwide an estimated 5.7% and 9.3% of people with 
ADHD have lifetime BN and BED respectively. Conversely, among people with BN and BED, 
14.8% and 10.2% have lifetime histories of ADHD respectively (Kessler et al., 2013). Studies 
have found increased rates of ADHD among ED patients, increased rates of EDs among ADHD 
patients, increased rates of both among obesity patients, and correlations between the 
prevalence of both disorders in community based samples. Evidence has also recently been 
extended to young pediatric samples. All relevant studies identified to date are displayed in 
table 1 and 2.  Table 1 displays all studies among ADHD or ED patients and table 2 displays all 
studies among obesity patients and non-patient samples. 
In regards to ADHD among ED patients (see table 1), all of the eight studies have 
focused on female, adult patients. Although only two utilized comparison groups, across all 
there is a trend of increased prevalence of ADHD among ED patients. For example, one study 
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reported that 21.2% of 189 females at an inpatient ED facility displayed six or more current 
ADHD symptoms (Yates, Lund, Johnson, Mitchell, & McKee, 2009). A similar investigation of 
females receiving either inpatient or outpatient ED treatment found that 21% had childhood 
ADHD compared to a 2.5% of comparison controls. Moreover, a third of the ED sample reported 
sub-threshold childhood ADHD symptoms (Seitz et al., 2013). Additionally, a large outpatient 
ED clinic reported a significant positive association between ADHD symptoms and the 
frequency of binge eating episodes among female patients (Fernández-Aranda et al., 2013). 
In regards to the twelve studies identified among ADHD patients (see table 1), a large 
portion utilized gender-mixed samples. Results varied in that significant rates of comorbid 
ADHD/ EDs was found among gender-mixed samples; however, the few studies that stratified 
by gender found evidence of the relationship only among females (see table 1). One 
investigation of a gender mixed pediatric sample found that ADHD patients had significantly 
more parent-reported BN symptoms compared to controls at an eight year follow up with 
medium effect sizes (Mikami et al., 2010). A case-control, longitudinal, family study of girls 
found that those with ADHD were 3.6 times more likely to develop an ED, and 5.6 times more 
likely to develop BN than age-matched controls (Biederman et al., 2007). A similar investigation 
of a large, longitudinal birth cohort found a 5.7 times increased risk for EDs among boys and 
girls with ADHD compared to those without ADHD (Yoshimasu et al., 2012). 
Four studies have evaluated both ADHD and binge eating among patients seeking 
treatment for obesity (see table 2). Three studies that used obese adolescent or adult samples 
noted significant associations between ADHD and binge eating (Cortese et al., 2006; Nazar et 
al., 2012; Nazar et al., 2014). These studies also found that ADHD is correlated with more 
severe BED and BN behaviors among weight loss seeking patients (Nazar et al., 2012; Nazar et 
al., 2014). However, the fourth was among a pediatric, gender-mixed sample and found no 
association between ADHD and disordered eating behaviors (Pauli-Pott, Becker, Albayrak, 
Hebebrand, & Pott, 2013). 
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Table 1. Comorbid ADHD/ ED Studies with ADHD and ED Patient Samples 
1st Author, Year 
Country Sample 
Patient 
Status Cases Controls Key Findings 
ADHD Rates in ED Patients 
Sokol, 1999  
United States 
Adult 
Female 
Not 
Reported 6 BN 7 HC 
Higher ADHD symptom scale scores 
among BN v. HC 
Wentz, 2005 
United Kingdom 
Adult 
Female 
Inpatient & 
Outpatient 
9 BN, 8 ANR, 
13 ANB NC 17% had childhood ADHD 
Blinder, 2006 
United States 
Adult 
Female Inpatient 
882 BN, 520 
ANR, 436 ANB, 
598 EDNOS 
NC 
Rates of ADHD by subtype: BN (9%), AN 
(3%), EDNOS (6%);  
No different in ADHD by ED subtype 
Fischer, 2007 
United States 
Adolescent1 
Female Outpatient 80 BN NC 2.9% had ADHD 
Yates, 2009 
United States 
Adult2 
Female Inpatient 
37 BN, 55 
ANR, 97 ANB NC 
5.3% met full criteria for ADHD; 
21.2% had at least six current symptoms 
Fernandez-
Aranda, 2013 
Spain 
Adult 
Female Outpatient 
95 BN, 43 AN, 
29 EDNOS, 
24 BED 
NC Positive correlation of ADHD symptoms and binge eating episodes 
Seitz, 2013 
Germany 
Adult3 
Female 
Inpatient & 
Outpatient 57 BN 40 HC 
BN v. HC: childhood ADHD (21% v. 
2.5%); adult ADHD (10% v. 2.5%);  
1/3rd of BN had childhood symptoms 
Stulz, 2013 
Switzerland 
Adult 
Female Inpatient 
6 BN, 7 ANR,  
5 ANB,  
14 EDNOS 
NC 29% of cases had ADHD symptoms;  No correlation of severity of each 
ED Rates in ADHD Patients 
Biederman, 1994 
United States 
Adult 
Male & Female Outpatient 101 ADHD 207 HC 
Higher rate of BN in ADHD v. HC among 
females; no BN among any males 
Mattos, 2004 
Brazil 
Adult 
Male & Female Outpatient 86 ADHD NC 9 had BED; 1 had EDNOS 
Kooij, 2004 
Netherlands 
Adult 
Male & Female Outpatient 45 ADHD NC 
9% (3 cases) had BN;  
1 with past BN and 2 with current BN 
Biederman, 2004 
United States 
Adult 
Male & Female Outpatient 219 ADHD 215 HC 
Higher rate of BN in ADHD vs. HC 
among females (11% v. 1%);  
no BN among any males 
Surman, 2006 
United States 
1 Pediatric 
2 Adult 
Male & Female 
Outpatient 
Pediatric: 280 
Adult 1: 101 
Adult 2: 219 
ADHD 
Pediatric: 242 
Adult 1: 207 
Adult 2: 215 
HC 
Rate of BN in ADHD vs. HC: 
Pediatric: Females (1% v. 0%); males 
(0% v. 0%); Adult 1: Females (12% v. 
3%); males (3% v. 0%); Adult 2: Females 
(11% v. 0%); males (0% v. 0%) 
Sobanski, 2007 
Germany 
Adult 
Male & Female Outpatient 70 ADHD 70 HC 
Higher rate of BED in ADHD vs. HC 
(11.4% v. 1.4%) 
Mikami, 2008 
United States 
Pediatric 
Female Outpatient 127 ADHD 82 HC 
Rate of BN symptoms: 5-10% in ADHD 
combined and 0-1% in ADHD inattention 
and control groups; no diagnosable BN 
Biederman, 2009 
United States 
Pediatric 
Male Outpatient 140 ADHD 120 HC No BN found in either ADHD or HC 
Mikami, 2010 
United States 
Pediatric 
Male & Female Outpatient 432 ADHD 264 HC 
Higher rate of BN symptoms in ADHD v. 
HC; no diagnosable BN 
Biederman, 
1999, 2006, 
2007, 2010 
United States 
Pediatric 
Female Outpatient 140 ADHD 120 HC 
Longitudinal Sample Follow-Ups: 
Intake: ADHD: 1% had AN, 2% had BN, 
HC: 0% had AN or BN;  
Year 5: Past year ED (HR=4.4, p=.06); 
ADHD 3.6x and 5.6x more likely to have 
lifetime ED and lifetime BN;  
Year 11: Lifetime ED (HR=3.5); Rate of 
past year ED in ADHD v. HC (7% v. 3%)  
Yoshimasu, 2012 
United States 
Pediatric 
Male & Female Outpatient 379 ADHD 758 HC Risk of ED in ADHD v. HC (HR: 5.68) 
Reinblatt, 2014 
United States 
Pediatric4 
Male & Female Outpatient 109 ADHD 143 HC
5 
Children with ADHD 16x more likely to 
binge eat; ADHD was positively 
associated with BMI and the relationship 
was partially mediated by binge eating 
Notes: ED=eating disorder; AN=Anorexia Nervosa; ANR=Anorexia Nervosa Restricting Subtype; ANB=Anorexia Nervosa 
Binge/Purge Subtype; BN=Bulimia Nervosa; BED=Binge Eating Disorder; EDNOS=Eating Disorder Not Otherwise Specified; 
HR=hazard ratio; HC=healthy control; NC=no controls 
1two were male; 265 patients under age 18; 3age range 15-35; 4avg. age of 10.8; 5psychiatric patients without ADHD 
 21 
Seven studies have investigated the comorbidity among non-patient populations (see 
table 2). All reported evidence of the comorbidity, with the exception of one Canadian study that 
found a significant difference in the number of ADHD symptoms between normal weight 
participants and participants that were obese. However, a lack of a significant difference in the 
number of ADHD symptoms between the two obese samples suggests an association between 
ADHD with obesity and not BED (Davis et al., 2009). Conversely, among a young sample, after 
adjusting for body mass index, children with ADHD were 12 times more likely to have loss of 
control eating syndrome (LOS-ES) (Reinblatt et al., 2015). Moreover, a large U.S. nationally 
representative survey study reported that the relationship only existed with BED and BN 
behaviors and not restrictive behaviors. Specifically, participants with self-reported sub-clinical 
childhood ADHD symptoms with no official diagnosis were twice as likely to report sub-clinical 
BN or BED behaviors (Bleck, Debate, & Olivardia, 2014). 
Associations between ADHD and binge eating have also been observed in young 
pediatric samples. With regards to current behaviors in younger samples, a retrospective chart 
review at two pediatric mental health clinics with participants that had an average age of 10.8 
years old found a significant association between ADHD and binge eating. Moreover, ADHD 
was also associated with being overweight or obese, and the relationship of ADHD with weight 
was partially, but not completely, mediated by binge eating (Reinblatt et al., 2014). A second 
study investigated the relationship between ADHD and loss of control eating among a 
community-recruited sample of children with an average age of eleven years old. Loss of control 
eating is sometimes used to describe BED in children as it is considered difficult to determine 
what would constitute an objectively large binge among growing children. Instead loss of control 
eating represents subjective binge eating (Reinblatt et al., 2015). After adjusting for body mass 
index, children with ADHD were twelve times more likely to have loss of control eating (Reinblatt 
et al., 2015). 
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Regardless of the presence of an ED, ADHD has separately been associated with 
subsequent obesity (Cortese et al., 2008). High rates of ADHD have been noted among patients 
seeking weight loss treatment. One investigation of adult females at a nonsurgical obesity 
treatment center reported a 28.3% rate of diagnosable ADHD (Nazar et al., 2012). Similarly, 
estimated rates of ADHD among patients seeking bariatric surgery range from 26% to 61% 
(Nazar et al., 2014; Nicolau et al., 2013). ADHD symptoms may be a risk factor for less success 
of weight loss and weight maintenance and difficulties with compliance in bariatric surgery 
follow-up (Nicolau et al., 2013). Although studies have investigated the comorbidity of ADHD 
and obesity separate from that of ADHD and EDs, one that explored mediating factors related to 
Table 2. Comorbid ADHD/ ED Studies with Obese and Non-Patient Samples 
1st Author, Year 
Country Sample 
Patient 
Status Cases Controls Key Findings 
ADHD and ED Rates in Obesity Patients 
Cortese, 2006 
France 
Adolescent 
Male & Female Inpatient 106 obese NC 
BN and ADHD symptoms significantly 
correlated even after controlling for 
depressive and anxiety symptoms 
Nazar, 2012 
Brazil 
Adult 
Female Outpatient 155 obese NC 
28.3% had ADHD; ADHD was correlated 
with more severe BED and BN symptoms 
Pauli-Pott, 2013 
Germany 
Pediatric 
Male & Female Outpatient 128 obese NC 
ADHD symptoms were not associated 
with any ED behavior 
Nazar, 2014 
Brazil 
Adult 
Female Outpatient 171 obese NC 
ADHD symptoms significantly predicted 
binge eating behavior 
Non-Patient Samples 
Neumark-
Sztainer, 1995 
United States 
Adolescents 
Male & Female Non-Patient 
689 ADD: school 
survey recruited 1,371 HC 
Higher rate of BED in ADD v. HC for both 
males and females 
Davis, 2006 
Canada 
Adult 
Female Non-Patient 
110: community 
recruited - 
ADHD was associated with overeating 
(i.e., binge, emotional, and external, and 
depressed overeating); overeating was 
associated with increased BMI 
Davis, 2009 
Canada 
Adult 
Male & Female Non-Patient 
60: community 
recruited, obese 
with BED 
61 HC; 
60 No-
BED OC 
Higher rate of ADHD symptoms in obese 
v. normal weight; no difference between 
obese with BED and obese without BED 
Kessler, 2013 
Worldwide 
Adult 
Male & Female Non-Patient 
12,413: WHO 
World Mental 
Health Survey 
Initiative 
- 
Among adults with lifetime ADHD: 5.7% 
had a history of BN and 9.3% had a 
history of BED; Among adults with 
lifetime BN and BED: 14.8% (OR=5.8) 
and 10.2% (OR=3.9) had lifetime ADHD 
Bleck, 2014 
United States 
Adult 
Male & Female Non-Patient 4,862: Add Health
1 - 
ADHD was associated with clinical ED 
and sub-clinical BN and BED but not AN 
behaviors among females; No ADHD/ ED 
association among males 
Bleck, 2014 
United States 
Adult 
Male & Female Non-Patient 
11,458: Add 
Health1 - 
Childhood ADHD symptoms were 
associated with adult BN symptoms but 
not associated with AN symptoms 
Reinblatt, 2015 
United States 
Pediatric2 
Male & Female Outpatient 
79: community 
recruited, over 5th 
weight percentile:  
- 
Children with ADHD were 12x more likely 
to have loss of control eating syndrome 
after controlling for BMI 
Notes: ED=eating disorder; BN=Bulimia Nervosa; BED=Binge Eating Disorder; BMI=body mass index; OR=odds ratio; HC=healthy 
control; NC=no controls; OC=obese controls; 1National Longitudinal Study of Adolescent to Adult Health; 2avg. age is 11 
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ADHD and obesity found that binge eating but not depression mediated the ADHD/ obesity 
relationship (Pagoto et al., 2009). 
 
 Hypotheses of Comorbid ADHD/ ED 
To date very little is known about the determinants of the comorbidity of ADHD and EDs.  
While there have been very few empirical investigations of either the determinants or underlying 
mechanisms to explain this comorbidity, several hypotheses have been suggested. Within a 
systematic review of the current evidence of the comorbidity, Cortese et al. (2007) suggested 
four potential hypotheses to explain the relationship: “1) inattention and/or impulsivity foster 
binge eating; 2) ADHD and binge eating share common neurobiological bases; 3) binge eating 
contributes to ADHD; and 4) psychopathological factors common to both binge eating and 
ADHD mediate the association” (Cortese et al., 2007, p.404). Similar hypotheses were recently 
suggested within the investigation of ADHD with loss of control eating among children. In order 
to explain the relationship, Reinblatt et al. (2015) proposed that the comorbidity of ADHD and 
loss of control eating could: “1) reflect the random base rates of [loss of control eating] and 
ADHD in the population; 2) result from an underlying common risk factor (such as impulsivity) 
leading to symptoms, or 3) reflect symptom overlap in these disorders, with ADHD presenting a 
behavioral form of impaired impulse control and LOC-ES presenting an eating based form of 
impaired impulse control” (Reinblatt et al., 2015, p.2). 
Based on these initial hypotheses, justifications of the hypotheses, and findings from 
other studies, the current study proposed three hypotheses of the underlying mechanisms of the 
ADHD/ED comorbidity. Hypotheses include: hypothesis one [H1]) ADHD and binge eating are 
the expression of a common genetic or neurobiological dysfunction that manifests itself as binge 
eating and ADHD; hypothesis two [H2]) psychosocial factors common to both binge eating and 
ADHD mediate the association between the two conditions; and hypothesis three [H3]) a third 
underlying mental health condition mediates the relationship between the two conditions. These 
 24 
hypotheses, suggested factors within each hypothesis, and the interaction between hypotheses 
all require further investigation. 
 
Proposed Underlying Mechanisms of Comorbid ADHD/ ED 
The Reward Deficiency Syndrome (RDS) has been proposed to explain the potential 
common genetic or neurobiological dysfunction (H1) (Cortese et al., 2007). The RDS is 
characterized by a lack of dopamine based natural award (Comings & Blum, 2000). This 
dopamine deficiency then leads someone to seek reward through behaviors, typically impulsive 
or risky behaviors (Blum et al., 2000; Blum et al., 1996; Blum et al., 1995; Comings & Blum, 
2000; Cortese et al., 2007). The RDS has been linked to ADHD, binge eating, and obesity; and 
in the case of the ADHD/ED comorbidity, someone with the RDS might present with impulsive 
behaviors that include both hyperactivity and binge eating (Blum & Noble, 2001; Comings & 
Blum, 2000; Noble, 2003; Wang, Volkow, & Fowler, 2002). 
Several neurotransmitters and genes have been associated with the syndrome including 
serotonin, norepinephrine, GABA, opioid, and cannabinoid neurons, all of which modify 
dopamine metabolism and dopamine neurons (Comings & Blum, 2000). Defects in the genes 
associated with the production of these neurotransmitters results in the RDS. These genes 
include Dopamine Receptor D1, Dopamine Receptor D2, Dopamine Receptor D4, Dopamine 
Receptor D5, Dopamine Transporter DAT1, Dopamine B-Hydroxylase, adrenergic a2A and a2C 
Receptor, Monoamine Oxidase A and B, COMT val158, and Serotonin Transporter 5HTT 
(Comings & Blum, 2000). 
Dopaminergic genes directly impact dopamine development, and thus are key genes 
associated with the RDS (Comings & Blum, 2000). The dopamine system genes are also the 
site for activation of the metabolism of ADHD psychostimulant medications (Li, Sham, Owen, & 
He, 2006). More specifically, the nine repeat and ten repeat genotypes of the dopamine 
transporter DAT1 have been associated with a range of risk taking behaviors including 
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delinquency, risky sex, risky drinking, and drug use (Guo, Cai, Guo, Wang, & Harris, 2010), as 
well as ADHD and EDs (Frieling et al., 2010; Swanson et al., 2000). The seven repeat genotype 
of the dopamine D4 receptor gene has been associated with mood disorders and substance use 
(Bobadilla et al., 2013), and has been observed at elevated rates in patients with ADHD (Bidwell 
et al., 2011; LaHoste et al., 1996; McClernon, Fuemmeler, Kollins, Kail, & Ashley-Koch, 2008; 
Swanson et al., 1998) and EDs (Bachner-Melman et al., 2007; Kaplan et al., 2008). 
Genes associated with serotonin also play a key role in dopamine production and the 
RDS (Comings & Blum, 2000). The serotonin transporter 5-HTTLPR has been associated with 
both ADHD (Bidwell et al., 2011) and EDs (Frieling et al., 2006; Urwin & Nunn, 2004; Verkes, 
Pijl, Meinders, & Van Kempen, 1996). Lastly, monoamine oxidase A (MAOA) is associated with 
the RDS as it impacts the production of neurotransmitters including dopamine, serotonin, and 
norepinephrine (Comings et al., 2000). MAOA has been associated with ADHD (Bidwell et al., 
2011; Kollins, McClernon, & Fuemmeler, 2005; McClernon et al., 2008), EDs (Urwin & Nunn, 
2004; Verkes et al., 1996), and obesity (Camarena et al., 2004). 
  In regards to H2, potential psychosocial factors include social and familial support and 
personality traits. Both peer rejection and parent-child relationships have been associated with 
ADHD and EDs (Mikami, Hinshaw, Patterson, & Lee, 2008); similarly, personality traits such as 
novelty seeking, self-directedness, obsessive compulsiveness, and perfectionism have also 
been linked to the comorbidity (Fernández-Aranda et al., 2013). All three factors (i.e., family 
support, peer support, and personality) have been observed as mediating the association 
between ADHD with other mental illnesses. Specifically, personality factors including 
neuroticism and impulsiveness have been found to mediate the relationship between ADHD and 
addictions (Davis, Cohen, Davids, & Rabindranath, 2015), and parenting behaviors mediate the 
relationship between ADHD and depression (Ostrander & Herman, 2006). One study linking 
ADHD with addictions suggested that the substance abuse might result as a self-medicating or 
coping behavior in the absence of adequate social support (Davis et al., 2015). Based on the 
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high rates of co-occurrence of ADHD, EDs, substance abuse, and depression, described in 
detail below, and conceptual similarities in these disorders, the mediating influences of family 
support, social support, and personality might also apply to the relationship between ADHD and 
EDs. 
  Cognitive psychological factors may impact the connection between ADHD and EDs, 
specifically working memory and cognitive control (National Institute of Mental Health, n.d.) 
Cognitive control may be explained by deficient inhibitory control, which is an expression of 
impulsivity (Cortese et al., 2007). Impulsive symptoms like interrupting and intruding are part of 
the diagnostic criteria for ADHD (APA, 2013), and binge eating has been repeatedly 
conceptualized as a dysfunction in impulse control (Engel et al., 2005; Fahy & Eisler, 1993; 
Rosval et al., 2006; Wiederman & Pryor, 1996; Wonderlich, Connolly, & Stice, 2004). Evidence 
indicates 40% of patients with BN have been observed with impulse control problems in other 
life domains beyond eating (Gurze Books, 2013; Waxman, 2009). More specifically, deficient 
inhibitory control manifests as poor planning and difficulties in behavior monitoring, both of 
which may lead to binge eating and may appear in behaviors that contribute to the diagnoses of 
both EDs and ADHD (Davis et al., 2006). 
  Impulsivity, the stem of cognitive control issues, has been hypothesized as the mediating 
link between ADHD and EDs by multiple authors (Cortese et al., 2007; Reinblatt et al., 2014; 
Reinblatt et al., 2015; Steadman & Knouse, 2014); however, two investigations of this 
hypothesis found mixed results. Among a sample of 50 undergraduate students, impulsivity, 
both self reported via the Barratt Impulsiveness Scale and an executive functioning self-restraint 
scale, as well as measured with a computerized go/no-go task, could not explain the observed 
association of ADHD with BED symptoms (Steadman & Knouse, 2014). However, another study 
found significant associations between both parent reported lack of impulse control and results 
of a computer based neuropsychological assessment task of impulsive control with ADHD and 
loss of control eating in children (Reinblatt et al., 2015). 
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  Lastly, a third underlying mental health condition may mediate the association between 
ADHD and EDs (H3). There are high levels of comorbidity across all mental illnesses with both 
ADHD and EDs having many noted comorbidities (Biederman et al., 2010; Blinder, Cumella, & 
Sanathara, 2006). The common comorbidities of depression, substance abuse, and anxiety 
disorders are all possible mediators between ADHD and EDs (Cortese et al., 2007). Psychiatric 
factors including depression, anxiety, and emotion regulation have been specifically 
hypothesized as potential mediators of the ADHD/ED relationship (Steadman & Knouse, 2014). 
Although not specifically proposed as an underlying mechanism, experiences of childhood 
abuse, both sexual and physical, may also mediate the relationship as childhood abuse and 
maltreatment has separately been linked to both ADHD (Erikson, 1968; Ouyang, Fang, Mercy, 
Perou, & Grosse, 2008) and EDs (Hall, Tice, Beresford, Wooley, & Hall, 1989; Wonderlich, 
Brewerton, Jocic, Dansky, & Abbott, 1997). 
  Although many have been proposed, to date only one potential underlying mechanism 
has been tested. The cognitive control, or impulsivity mediator has been explored but findings 
were mixed as described above. All other hypothesized factors have not yet been evaluated. 
Moreover, with the exception of the RDS and associated genetic factors, the majority of the 
predicted underlying factors were proposed independently of each other. An empirical 
evaluation is needed of the three hypotheses and associated factors in order to better 
understand how and why this comorbidity develops. A simultaneous investigation of the three 
hypotheses would allow for evaluation of each individual factor as well as the interaction of the 
factors. Results could help to develop a comprehensive model of the combined and interacting 
underlying mechanisms, which can then be used for improved prevention and treatment efforts. 
 
Comorbid ADHD/ ED among Males   
 Current literature related to the ADHD/ED comorbidity has provided a theoretical 
background to guide the development of an understanding of this comorbidity among females. 
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However, there are significant gender differences in terms of manifestation and symptomology 
(Núñez-Navarro et al., 2012), risk factors (Strother, Lemberg, Stanford, & Turberville, 2012), 
and outcomes of ED (Stoving, Andries, Brixen, Bilenberg, & Horder, 2011) and based on the 
female focus, our knowledge of gender differences related to comorbid ADHD/ED is limited. 
While the majority of epidemiological studies have focused on females, the comorbidity has also 
been observed in gender mixed samples (Cortese et al., 2006; Davis et al., 2009; Fischer & 
Grange, 2007; Mattos et al., 2004; Mikami et al., 2010; Neumark-Sztainer, Story, Resnick, 
Garwick, & Blum, 1995; Sobanski et al., 2007). While there is evidence of its existence, 
understanding of the comorbidity in regards to underlying factors and characteristics associated 
with this subset of males is still underdeveloped. 
While many of the proposed underlying mechanisms may hold true for both genders, 
some factors may be gender-specific. As one example, gender differences have been noted 
among the rates of comorbid mental illnesses among people with ADHD. Specifically, 
prevalence of major depression and generalized anxiety disorder were higher among females 
with ADHD, while comorbid substance use disorders were more common among males 
(Hesson & Fowler, 2015). While all three of these disorders have been proposed as potential 
mediators between ADHD and EDs, this finding suggests that female specific results of the 
underlying mechanism cannot be assumed among males. Moreover, females worldwide have 
been found to report higher levels of neuroticism and conscientiousness than males (Schmitt, 
Realo, Voracek, & Allik, 2008). In an investigation of the link between ADHD and addictions, it 
was reported that females with ADHD had higher scores in binge eating assessments while 
males had high scores for hypersexual behavior (Davis et al., 2015). These and other potential 
differences suggest that an independent investigation of the underlying mechanisms of the 
comorbidity among males is needed. 
EDs among males are generally considered underdiagnosed and misunderstood 
(Smink, van Hoeken, & Hoek, 2012; Strother et al., 2012). While binge eating is the most 
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common ED amongst males (Hudson et al., 2007; Striegel-Moore & Franko, 2003; Swanson et 
al., 2011), to date the male ED literature has generally focused on exercise behavior (Nunez-
Navarro et al., 2012; Stoving et al., 2011; Strother et al., 2012) and restriction among 
homosexual males (Fernandez-Aranda et al., 2004; Shiltz, n.d.). Men with ADHD and comorbid 
binge eating may constitute a different demographic category of males as compared to more 
studied groups in prior male ED research. 
There are very few ED prevention options for males, with this gap particularly 
problematic for prevention of binge eating (Ciao et al., 2014). Targeting males at risk for 
comorbid ADHD/ EDs for primary ED prevention may be an initial step to address this gap. 
However, in order to be able to target males at risk, information is needed to help identify those 
at risk. Determining any demographic, physical health, and behavioral health characteristics 
specific to this group of men could aid in the development of targeted prevention programming. 
Some characteristics of interest may include intelligence, exercise behaviors, weight, 
delinquency behavior, and sexual behaviors. Both intelligence and personality might be 
important traits that could impact the ability to identify someone at risk for comorbid ADHD/ED.  
One study suggested that a female ED patient’s high intelligence and perfectionism might have 
contributed to the lack of diagnosis of her comorbid ADHD (Ioannidis, Serfontein, & Müller, 
2014). Perceived intelligence may also impact academic success. This coupled with the impacts 
of ADHD on academic achievement may be the driving force for the low rates of academic 
success among adolescents with ADHD. Specifically, 25% of children with ADHD are held back 
a grade and 36% do not finish high school (Koch, 1999). 
Based on the shared impulsive nature of ADHD and EDs, additional impulse related 
behaviors such as delinquent behavior and hypersexual behavior may be more common among 
males with both disorders. Increased sexual behavior has been noted among males with ADHD 
(Davis et al., 2015); and high rates of ADHD, up to 72% of males, have been noted within 
juvenile detention facilities (Koch, 1999). It has also been reported that 25% to 45% of 
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adolescents with untreated ADHD develop a conduct disorder or delinquent behaviors, 18% to 
25% abuse illegal substances, and 25% are involved in a teen pregnancy (Koch, 1999). 
Increased exercise behaviors as well as performance enhancing substance use are 
common ED behaviors in males (Blouin & Goldfield, 1995; Kanayama, Barry, Hudson, & Pope 
Jr, 2006; Pope, Kanayama, & Hudson, 2012; Pope, Katz, & Hudson, 1993). With links between 
ADHD and substance abuse (Disney, Elkins, McGue, & Iacono, 1999; Hesson & Fowler, 2015), 
as well as the noted potential for physical activity on ADHD treatment (Smith et al., 2013), these 
factors may be helpful in identifying males struggling with both disorders. Additionally, males 
with EDs are more likely to have a history of obesity (Fernández-Aranda et al., 2004; Núñez-
Navarro et al., 2012), and as described above ADHD is also linked to obesity. EDs and ADHD 
medications are associated with heart health issues (McElroy et al., 2015; Striegel-Moore & 
Franko, 2003), subsequently obesity, obesity related, and heart related outcomes may be 
noteworthy and require close monitoring in males with comorbid ADHD/ED. 
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CHAPTER THREE: METHODS 
 
Based on the current literature related to the ADHD/ED comorbidity, the goal of this 
study is to increase the understanding in regards to the underlying mechanisms of the 
ADHD/ED comorbidity. The study does so by addressing the following overall research question 
(RQ): what are the underlying mechanisms of the ADHD/ED comorbidity and how do these 
factors interact? In order to answer this question, the project consists of two aims with several 
accompanying sub-RQs. 
 
Specific Aims 
Aim One: Evaluate a Model of the Underlying Mechanisms of the ADHD/ED 
Comorbidity. Aim one focuses on simultaneously investigating the three hypotheses of the 
underlying mechanisms of the comorbidity among females. Guided by an innovative conceptual 
framework this aim addresses the following three sub-RQs: AIM1.RQ1) Which genetic risk 
factors are associated with the comorbidity? AIM1.RQ2) Which risk regulators (i.e., 
psychosocial and psychiatric factors) are associated with the comorbidity? AIM1.RQ3) How 
does the presence of the risk regulators impact the association (i.e., mediate) between the 
genetic factors and comorbid ADHD/ EDs? 
Aim Two: Explore the comorbidity and underlying mechanisms of ADHD/ED among 
males. Aim two focuses on the comorbidity among males, as evidence to date has 
overwhelmingly been focused on females, leaving a gap in our understanding of the comorbidity 
among males. This aim will explore the demographic, physical health, and behavioral health 
profile of males with the ADHD/ED comorbidity as well as the association of the proposed 
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underlying mechanisms with male comorbid ADHD/ED via the following sub-RQs: AIM2.RQ1) 
Are there any differences in demographic, physical health, or behavioral health characteristics 
between men with comorbid ADHD and EDs compared to men with ADHD alone, ED alone, and 
all men? AIM2.RQ2) What underlying mechanisms are associated with the comorbidity among 
males? 
 
Conceptual Framework 
As previously stated, this dissertation project aims to simultaneously investigate the 
three proposed hypotheses and potential factors within each hypothesis. In order to do so, this 
study is guided by a conceptual framework that incorporates aspects of five models, including 
the Biopsychosocial Model (Engel, 1980), the Life Course Approach (Ben-Shlomo & Kuh, 2002), 
the Risk Regulator Framework (Glass & McAtee, 2006), the Research Domain Criteria Matrix 
(Morris & Cuthbert, 2012; National Institutes of Mental Health, n.d.), and the Person-
Environment Transaction Theory (Caspi & Roberts, 2001). Components of each theory are 
incorporated into one collaborative framework to account for the combination of hypothesized 
underlying mechanisms that cannot be explained by one theory alone. 
 
Biopsychosocial Model 
The base of the conceptual framework is the Biopsychosocial Model. First described in 
1980, the model proposed a new perspective that recognizes the connection between the body 
and mind as an alternative to the traditional biomedical model of clinical practice (Engel, 1980). 
The model incorporates a hierarchical system to explain health conditions. Levels of the system 
range from atoms and molecules through individual behavior and community and societal 
elements (Engel, 1980). One key aspect of the model is that nothing exists in isolation and that 
health is influenced by a complex interaction of biological, psychological and social factors 
(Engel, 1980). The Biopsychosocial Model serves as the base of the proposed conceptual 
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framework as it allows for the integration of all three proposed hypotheses of the underlying 
mechanisms of the ADHD/ED comorbidity (see figure 1). Specifically, the model accounts for 
the hypothesized genetic factors (H1), the psychosocial factors (H2), and the psychiatric factors 
(H3). 
 
 
Figure 1: Hypothesized Underlying Mechanisms of Comorbid ADHD/ ED in a Framework 
Combining the Biopsychosocial Model and Life Course Theory 
 
Life Course Approach 
While the Biopsychosocial Model allows for the simultaneous investigation of all three 
hypotheses, it fails to incorporate the temporal association between the factors. The genetic 
components of the underlying mechanism are developed prior to birth with the biological 
influence of these genetic polymorphisms manifesting over time. Moreover, while it is expected 
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that the psychosocial and psychological factors will be correlated, they are not expected to 
occur at the same point in time. Subsequently the Biopsychosocial Model is missing a needed 
life course or longitudinal component. The Life Course Approach, which is typically used in 
epidemiology, helps guide exploration of the long-term effects of physical and social exposures 
on chronic disease (Ben-Shlomo & Kuh, 2002). This approach includes the investigation of 
biological, behavioral, and psychosocial exposures or pathways over time in order to determine 
the impact of these pathways on associated health outcomes (Ben-Shlomo & Kuh, 2002; Elder, 
Johnson, & Crosnoe, 2003). It is hypothesized that the genetic factors are determined in 
gestation while psychosocial and psychiatric factors appear over time (Elder et al., 2003). 
 
Risk Regulator Framework 
While the integrated Biopsychosocial Model and Life Course Approach helps to explain 
the interaction of the three hypotheses, it does not account for hypothesized causal 
associations. H1 suggests that biological factors cause the appearance of the comorbidity, while 
H2 and H3 suggest that psychosocial and psychiatric factors do not necessarily cause the 
comorbidity but rather mediate the association between the two disorders (i.e., regulate risk but 
not causal mechanisms). The Risk Regulator Framework, developed by Glass and McAtee, 
helps incorporate the difference between risk factors and risk regulators, allowing for 
explorations of the hypothesized streams of causations (Glass & McAtee, 2006). The Risk 
Regulator Framework states that genetic and biological factors and biological systems are 
influenced by exposures overtime, which then influences the development of a behavior (Glass 
& McAtee, 2006). 
Concomitantly, the built and social environments provide both opportunities for or 
restraints on the development and manifestation of a behavior (Glass & McAtee, 2006). A key 
component of the framework is the concept of a risk regulator, which was developed based on a 
perceived need for a new class of variables that influence behavior but do not fit the typical risk 
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factor definition in that a risk factor causes disease. Glass and McAtee provide poverty as an 
example of a risk regulator; while poverty is associated with many adverse health behaviors it 
does not directly cause any single disease (Glass & McAtee, 2006). 
 
 
Figure 2: Integrated Conceptual Framework of the Three Hypotheses and Proposed 
Underlying Mechanisms of Comorbid ADHD/ ED 
 
The original definition of risk regulators was aimed at broad level factors such as the 
built environment, conditions of work, and laws and policies (Glass & McAtee, 2006); however, 
the proposed conceptual framework expands the concept of risk regulators to account for the 
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mediating effect of the psychosocial (H2) and psychiatric (H3) factors associated with ADHD/ED 
comorbidity. The proposed factors within H2 and H3 are not predicted to cause the comorbidity 
but rather are associated with the comorbidity and may influence the manifestation of the both 
disorders within the context of biological risk factors, suggesting that they regulate, or mediate, 
the risk of the genetic predictors. Figure 2 incorporates the Biopsychosocial Model and Life 
Course Approach with the Risk Regulator Framework. As can be seen in figure 2, the biological 
dimension of the Biopsychosocial Model is represented in the genetic substrate and both the 
psychological and social dimensions are represented in the risk regulators. The Life Course 
Approach is incorporated in that the “underwater” genetic substrate represents the gestational 
period and the risk regulators and development of the comorbidity occur over time after birth or 
“above water”. 
 
Research Domain Criteria Matrix 
Framing the conceptual framework through the Risk Regulator and Biopsychosocial 
Models also incorporates concepts from the Research Domain Criteria (RDoC) Matrix. The 
current mental health literature related to identification and diagnosis is split between the hard 
and social sciences; the goal of RDoC is to integrate these fields (Insel et al., 2010; Sanislow et 
al., 2010). The RDoC Matrix was conceptualized and developed by the National Institute of 
Mental Health as a new classification system to improve understanding of mental illness (Insel 
et al., 2010; National Institutes of Mental Health, n.d.). Previous criticism of the diagnostic 
criteria for many mental illnesses suggested that clinical diagnoses fail to align with emerging 
neuroscience and genetics research (Insel et al., 2010). RDoC proposed that theoretically, if we 
can identify specific genetic, neurobiological, and behavioral sequences that predict the 
development of a disorder or potential treatment impacts, then neurobiology based screening 
tests could be used to identify patients and improve outcomes (Insel et al., 2010; National 
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Institutes of Mental Health, n.d.) While this may be a distant future, the conceptual framework of 
this project can guide future research aiming towards this long-term goal.   
RDoC comprises a matrix classifying brain disorders by domain or construct (e.g., 
cognitive systems, arousal) and unit of analysis (e.g., genes, cells, behavior) (Insel et al., 2010; 
Morris & Cuthbert, 2012). Reflecting the hierarchy of the Biopsychosocial Model, units of 
analysis range from genetics through the individual, family, and societal level, which each levels 
predicted to impact a mental illness (Insel et al., 2010). The proposed conceptual framework of 
the underlying mechanisms of the ADHD/ED comorbidity addresses the long-term goal of RDoC 
by incorporating genetic, psychosocial, cognitive, and psychiatric components within the model. 
A second goal of RDoC is to identify fundamental behavioral components that may span 
multiple disorders and can be explored through neuroscience (Sanislow et al., 2010). The 
cognitive systems domain, specifically the cognitive control construct, cites both dopamine and 
serotonin at the genetic level and impulsive, unplanned, and reward-seeking behaviors at the 
behavior level (National Institutes of Mental Health, n.d.). Moreover, RDoC recognizes that 
many mental illnesses are neurodevelopmental disorders. Therefore addressing development 
issues across a variety of life span phases is a critical consideration for the RDoC matrix 
(National Institute of Mental Health, n.d.); providing further support for incorporating the Life 
Course Approach and RDoC constructs into the proposed conceptual framework. Another 
RDoC goal is to develop an improved understanding of cognitive control in relation to ADHD, 
juvenile bipolar disorder, and conduct disorders (National Institute of Mental Health, n.d.). 
Through the current investigation of cognitive control as a potential factor within the context of 
comorbid ADHD/ED, this study could provide some information towards addressing this goal.  
 
Person-Environment Transaction Theory 
 Lastly, with the inclusion of personality traits in the psychosocial risk regulators, the 
conceptual framework also incorporates concepts from the person-environment transaction 
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theory. The theory was introduced within a description of the development of personality across 
the life course and specifically states that biological and social events often accentuate pre-
existing personality differences between people (Caspi & Roberts, 1990, 2001). In other words, 
behavior is predicted by the interaction of personality traits and the environment. This theory is 
supported in the conceptual framework in that personality traits (i.e., risk regulators) interact with 
both the environment (i.e., social factors) and the environment of the individual (i.e., genetic 
factors), to impact behavior (i.e., ADHD/ED behaviors). This theory suggests that personality 
changes over time based on interactions with environmental factors; accordingly, the personality 
factors within the conceptual framework be assessed at multiple time points. 
 
Benefits of the Proposed Framework 
 The conceptual framework combining the Biopsychosocial Model, the Life Course 
Approach, the Risk Regulator Framework, the RDoC Matrix, and the Person-Environment 
Transaction Theory allows for a complete understanding of the associations of the underlying 
mechanisms with the ADHD/ED comorbidity that could not be explained by one theory alone. 
The combination of construct from all of these theories helps provide the needed framework for 
an complex investigation of the ADHD/ED comorbidity. Based on extensive reviews, there are 
no other known theories that can incorporate all of the need constructs of this investigation.   
The proposed model incorporates several aspects that can be compared to the widely 
used Socioecological Model (Glanz, Rimer, & Viswanath, 2008), which helps explore health 
behaviors and conditions through the interaction of factors at several levels ranging from micro 
to macro levels (Glanz et al., 2008). The SEM model is similar to the Biopsychosocial Model, 
however it excludes the needed life course approach to explore impacts of factors over time as 
well as factors developing in gestation. Moreover, while the visualization of the conceptual 
framework is heavily based on the Risk Regulator Framework, this framework alone cannot 
explain the full picture of underlying mechanisms, as it is not specific to mental or behavioral 
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health. The combination of these five theories provides an opportunity for a unique 
understanding that could not be explained otherwise. 
 
Application of the Conceptual Framework 
Figure 2 depicts the full conceptual framework along with pathways of interest. The 
theories described above are combined to provide a complete picture of the potential underlying 
mechanisms of the ADHD/ED comorbidity. The proposed model states that the observable 
factors serve as “risk regulators” that influence the risk of developing the health issue (i.e., 
comorbid ADHD/ED) over time by interacting with that person’s genetic and biological make-up. 
The framework also includes proposed pathways that independently illustrate the three 
proposed hypotheses, as well as how the risk regulators and genetic substrate are predicted to 
interact to influence the manifestation of the comorbidity.  
The first three pathways were included based on the Risk Regulator Framework and 
Biopsychosocial Model. P1 denotes that risk factors within the genetic substrate are associated 
with the development of ADHD and EDs independently. P2 shows that the risk regulators may 
increase or decrease the risk of developing either ADHD or an ED. P2 is displayed as dotted 
lines as these risk regulators are not proposed to cause the development of either disorder but 
each in conjunction with other risk regulators, may impact the odds of developing the disorders.  
P3 was added to indicate the relationship between the genetic factors and risk regulators based 
on the Biopsychosocial Model, which suggests an interaction of the different domains. 
The remaining pathways, P4-P6 investigates the three proposed hypotheses of the 
underling mechanism of the ADHD/ED comorbidity. More specifically, P4 investigates which 
genetic risk factors are associated with the comorbidity (H1). P5 investigates the relationship of 
the risk regulators with the comorbidity (H2 & H3). As with P2 this is displayed as a dotted line 
as the risk regulators are not predicted as direct risk factors to the comorbidity; instead they are 
proposed to mediate the connection between ADHD and EDs. Lastly, P6 investigates the 
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interaction of these three hypotheses by determining how the presence of the risk regulators 
impacts the association (i.e., mediate) between the genetic factors and comorbid ADHD/ EDs. 
This last pathway allows for an investigation into how the three hypotheses interact. 
This conceptual framework helps expand the current descriptive and theoretical 
ADHD/ED literature by developing a comprehensive model within which future research can be 
framed. No single underlying mechanism can alone predict the development of the ADHD/ED 
comorbidity; however, the entire model (i.e., a combination of multiple interacting factors), can 
be used to develop screening tools to identify individuals with the specific sequence of 
underlying mechanisms that might increase their odds for developing the comorbidity. This 
conceptual framework explore mental illness from a holistic approach, which may particularly 
benefit children and adolescents with comorbid ADHD and EDs as these disorders have many 
broad ranging implications for several life domains. 
 
Study Design 
This study’s conceptual framework incorporates a large number of variables, which in 
combination with its complexity, requires a very large sample size. Based on available 
resources, collecting and processing genetics data, as well as variables across the life span 
would not be feasible. Based on these factors, this study utilized secondary data in order to 
obtain the large sample and wide range of variables needed to address the RQs. This method 
allows for simultaneous investigation of all proposed hypotheses related to the model as well as 
the use of variables measured across time. While there are many large secondary sources that 
collect information on ADHD and EDs, the National Longitudinal Study of Adolescent to Adult 
Health (Add Health) is the only secondary source that collected the psychosocial, psychiatric, 
and genetics variables needed to answer the proposed RQs. Moreover, its longitudinal design 
fits well with the conceptual framework. 
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Data Source 
The Add Health study tracked a nationally representative sample of adolescents over 
many years. It began with wave I (1994) by interviewing a cohort of 20,745 students in seventh 
through twelfth grade. Students were interviewed at home with parental consent. There have 
been three subsequent follow-up home-based interviews; wave II (1995-1996), wave III (2001-
2002), and wave IV (2007-2008) (Harris, 2011; Harris, Halpern, Whitsel, Hussey, & Tabor, 
2009). The theoretical framework used for collection of the study’s data mirrors the proposed 
conceptual framework of the current study. Specifically, Add Health used an integrative life 
course theoretical framework to investigate the associations between context, behavior, and 
biology to determine how factors influence health and well being from childhood to adulthood 
(Carolina Population Center, 2014). 
 Although the data fit the needs of this study very well, there are several limitations to 
consider. First the data was not collected for the purposes of testing the specific RQs. Secondly, 
all variables, except for genetic genotypes, were self-reported and retrospective. In early waves 
these self-reports were provided by adolescents, which may bring additional bias. However, 
previous scale development of Add Health data, including scales of emotional distress, deviant 
behaviors, self-esteem, parent-family connectedness, and substance use have reported 
acceptable internal consistency, reliability, and moderate correlations between conceptually 
related constructs (Sieving et al., 2001). Lastly, the timing of each variable’s collection is a 
limitation as some are collected out of the hypothesized order. For example genetics data was 
collected at wave IV, after most of the risk regulating factors were collected, while the 
conceptual framework for the current project proposed that biological factors influence the 
development of the risk regulating factors. However, this is the only dataset that allows for an 
investigation of the large, complex framework of the underlying mechanism. Moreover, this will 
be the first investigation into the associations proposed in the framework, thus despite 
limitations, this descriptive study design will help provide initial information about the underlying 
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mechanisms of the comorbidity. Results of which can be used to reduce the complexity of the 
model and allow for more feasible primary data collection to further test the model with 
prospective data. 
 
Participants 
 Add Health recruited 20,745 participants at wave I; specifically, 10,265 males and 
10,480 females were initially interviewed. The current study used data from waves I, III, and IV. 
A total of 13,034 participants, 5,951 males and 7,083 females, completed interviews at each of 
these waves. Due to a complex sampling design, survey weights were applied to all analyses; 
thus 746 participants (345 male, 401 female) missing information for the longitudinal wave I, III, 
and IV grand sample weight were excluded from analysis. 
Due to the importance of genetics to the research question, an additional 670 
participants (320 males, 350 females) missing genetics data were excluded from analysis. 
Saliva samples were collected among a subset of participants at wave III and among the full 
sample at wave IV. Missing genetics data resulted from either refusal to consent to collection, 
issues related to saliva collection, or issues related to genotype extraction; however, significant 
efforts were made to minimize the amount of missing data. 
Of the 15,140 participants interviewed at wave IV, 96% consented to providing a sample 
for genotyping. Samples were collected by trained and certified interviewers who were supplied 
with Blaise computer-assisted interview programs that provided step by step instructions and 
help screens as well as a hard-copy reference guides to help with the collection process 
(Smolen et al., 2013). With regards to analysis of the saliva samples, each sample was 
processed twice, on different days, and by different investigators. A third investigator then 
reviewed the results and in the case of any missing data or discrepant results, analysis was run 
a third time. Additionally, if genetic results were available from wave III but not wave IV, Add 
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Health combined the genotype data for the given participant from wave III into the wave IV 
dataset (Smolen et al., 2013). 
Lastly, due to the central importance of ADHD and EDs, an additional 81 participants (38 
males, 43 females) missing those variables were excluded. This resulted in a final sample size 
of 11,537 participants, with 6,289 females for aim one and 5,248 males for aim two. There were 
no statistically significant differences between those included and those excluded due to 
missing genetics, ADHD, or ED variables on all other hypothesized underlying mechanisms, or 
race, education, parent education, or family income. 
 
Measures 
The main constructs of this study are ADHD, EDs, and the comorbidity of the two 
disorders. In the development of the conceptual framework predicted underlying mechanisms 
were categorized into several groups including a genetic substrate, social factors, cognitive 
factors, personality factors, and psychiatric factors. All proposed scales were subjected to 
sample weighted confirmatory factor and reliability analyses. Based on the gender stratification 
of the two aims, each scale was evaluated separately by gender. 
Confirmatory factor analyses (CFA) were performed in MPlus 7 using either weighted 
least squares means and variance adjusted (WLSMV) or maximum likelihood estimators with 
robust standard errors (MLR) estimators. WLSMV was used for the CFA models of ADHD and 
EDs to account for the binary nature of the items (Proitsi et al., 2011). MLR was used for all 
other CFA models with continuous factors to account for sample weighting. Several fit indices 
were used to evaluate model fit, including chi-square test of model fit, comparative fit index 
(CFI), root mean square error of approximation (RMSEA), weighted root mean square residual 
(WRMR), and standardized root mean square residual (SRMR). 
The chi-square test of model fit compares the sample and fitted covariance matrices with 
a p-value greater than .05 indicating good model fit (Hu & Bentler, 1999; Schreiber, Nora, 
 44 
Stage, Barlow, & King, 2006; Yu, 2002). However, sample size is used in the calculation of the 
chi-square value, and thus it is sensitive to sample sizes (Hu & Bentler, 1999). Due to the large 
sample size (females=6,289, males=5,248), although chi-square test values are reported, these 
results did not impact conclusions related to model fit. Indicators of good model fit were based 
on the following suggestions: CFI (>.95), RMSEA (<.06), SRMR (<.08), and WRMR (<1.0) (Hu 
& Bentler, 1999; Schreiber et al., 2006; Yu, 2002). These cut-off criteria have been found 
acceptable with sample sizes over 250, and for both categorical and continuous outcomes, with 
the exception of SRMR with categorical data (Schreiber et al., 2006; Yu, 2002). Analyses of 
residuals was also performed to evaluate fit with a standardized residual over two indicating a 
lack of fit in the corresponding element of the model. 
 
ADHD and ED Indicators 
Separate indicator variables were constructed for ADHD and EDs.  These indicators 
were then used to construct a comorbid ADHD/ ED indicator as well as a categorical variable of 
disorder status.  
 
ADHD Indicator. Figure 3 depicts the construction of the ADHD indicator variable. 
Participants were considered to have reported ADHD if they reported clinical ADHD, sub-clinical 
ADHD, or both.  Clinical ADHD (i.e., diagnosed) was assessed at wave IV. Participants were 
considered to have clinical ADHD if they responded yes to the yes/no question: “[have you] ever 
been told by a doctor, nurse, or other health care provider that [you] had attention problems or 
ADD or ADHD”. Sub-clinical ADHD (i.e., some symptoms or behaviors but not all criteria for a 
clinical diagnosis) was assessed at wave III, where participants were asked to retrospectively 
evaluate their behaviors between age five and twelve pertaining to seventeen DSM ADHD 
symptoms (see figure 3) (APA, 2000, 2013). Response choices were on a four-point Likert scale 
ranging from “never or rarely” to “very often”. Participants were considered to have sub-clinical 
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ADHD if they reported the presence of at least six ADHD symptoms “often” or “very often”; thus 
meeting the symptomology requirement for a diagnosis but not all criteria (e.g., duration, level of 
impairment) (APA, 2000, 2013). Questions assessing sub-clinical ADHD symptoms were 
developed with the ability of stratifying by ADHD DSM IV sub-type. However, based on recent 
changes to the DSM V in which sub-groups were replaced by predominant presentations due to 
the instability of the sub-types (APA, 2000, 2013), participants were considered to have reported 
six or more symptoms regardless of sub-type.  
 
 
Figure 3. Construction of the ADHD Indicator Variable 
 46 
 Previous analyses with this specific ADHD scale found adequate internal consistency 
with Cronbach’s alpha estimates ranging from 0.86 to 0.91, and a split half reliability of 0.86 
(Beaver, Nedelec, Rowland, & Schwartz, 2012; Kollins, McClernon, & Fuemmeler, 2005). 
Moreover, childhood learning and behavioral problems are highly comorbid with ADHD 
(Boutros, 2013; Mayes, Calhoun, & Crowell, 2000), and previous investigations found that 
respondents that reported six or more ADHD symptoms in childhood were more likely to also 
report a learning or behavior problem at wave I and ADHD medication use at wave III (Kollins et 
al., 2005). 
CFA results demonstrated adequate fit with both the female (see appendix A, figure A1) 
and male (see appendix A, figure A2) samples. Among females, CFA of the seventeen 
symptoms items resulted in the following fit indices: Χ2(df=119)=893.66, p<.001; RMSEA=.03; 
CFI=.96; and WRMR=2.03. Although the WRMR was above the cut-off of 1.00, examination of 
residuals confirmed fit. The scale also demonstrated adequate reliability with a Cronbach’s 
alpha of .85. Results were almost identical among the males with a Cronbach’s alpha of .86 and 
the following fit indices: Χ2(df=119)=732.62, p<.001; RMSEA=.03; CFI=.97; WRMR=2.00, and 
as with females, an examination of residuals confirmed fit. 
 
Eating Disorder Indicator. Figure 4 depicts the construction of the ED indicator variable. 
As with ADHD, participants were considered to have reported an ED if they reported either a 
clinical ED, sub-clinical disordered eating behaviors, or both. Both clinical and sub-clinical 
indicators were measured at wave III. The participant was considered to have a clinical ED if 
they responded yes to the yes/no question asking “[have you] ever been told by a doctor that 
[you] had an ED, such as Anorexia Nervosa or Bulimia”.  
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Figure 4. Construction of the Eating Disorder Indicator Variable 
 
Guided by previous methodology, participants were considered to have a sub-clinical ED 
if they responded yes to using any disordered eating behaviors within the past week, thus 
meeting symptomology but not all criteria needed for a diagnosis (e.g., duration or frequency) 
(Conley & Boardman, 2007; Fuemmeler, Dedert, McClernon, & Beckham, 2009). Disordered 
eating behaviors were grouped into disordered weight loss and maintenance behaviors and 
binge eating behaviors. For the disordered weight loss and maintenance behaviors, participants 
were first asked if they were currently trying to lose weight or stay the same weight. If so, they 
were then read a list of weight loss methods and asked which were used in the past seven days 
in order to lose or maintain weight. Disordered weight loss and maintenance methods included 
self-induced vomiting, laxative use, diuretic use, weight loss pill use, or food supplements used 
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to replace a meal or to reduce appetite. Binge eating behavior in the past seven days was 
assessed via the following indicators: “have you eating so much in a short period that you would 
have been embarrassed if others has seen you do it” or “have you been afraid to start eating 
because you thought you wouldn’t be able to stop or control your eating”. These disordered 
eating behavior indicators were assessed on a yes/no scale and have been used in past studies 
with other samples (Neumark-Sztainer et al., 2006). 
Analysis of the two sub-clinical factors results demonstrated a very well fit and reliable 
scale for both females (see appendix B, figure B1) and males (see appendix B, figure B1). 
Results were similar between the genders with the following fit indices for females: 
Χ2(df=13)=16.52, p=.22; RMSEA=.01; CFI=.99; WRMR=.68; and the following indices for males: 
Χ2(df=13)=21.08, p=.07; RMSEA=.01; CFI=.95; WRMR=.78. Cronbach’s alpha values were .88 
and .89 for females and males respectively. 
 
Comorbid ADHD/ ED. Participants were considered to have comorbid ADHD/ED if they 
reported both ADHD and ED based on the indicators described above. For comparisons, a 
disorder status variable was created in which participants were categorized as having neither 
disorder, ADHD alone (i.e., no ED), ED alone (i.e., no ADHD), or comorbid ADHD/ED. 
 
Genetic Substrate 
 The genetic substrate is comprised of candidate genes proposed to be link to the 
ADHD/ED comorbidity via the Reward Deficiency Syndrome (RDS).  Available genetic 
candidates included in this study are dopamine receptor DRD4, dopamine transporter DAT1, 
serotonin transporter HTTLPR, and monoamine oxidase A. Saliva samples collected at wave IV 
were packaged and shipped to a central lab for DNA extraction, genotyping, and archiving. 
Genotype data was reported as the number of repeat sequences of a given polymorphism on 
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each allele. Genetic variables were constructed as bivariate indicators of if the specific repeat 
sequence, described below, was found on either allele A, or allele B, or both. 
 
Dopaminergic Genes. The dopamine D4 receptor gene contains a 48 bp VNTR 
polymorphism in the third exon, which is composed of ten alleles with two to eleven repeats. An 
indicator was constructed for the seven repeat pattern in that participants were considered to 
have any seven repeats if they had seven repeats on either allele or both alleles. The dopamine 
transporter DAT1 contains a 40 bp VNTR in the 3' untranslated region of the gene. Two 
indicator variables were constructed to identify any nine repeats and any ten repeats. 
 
Serotonin Gene. The serotonin transporter 5-HTTLPR, contains a 44-bp insertion / 
deletion polymorphism in the promoter region of the serotonin transporter (SLC6A4) gene 
(Smolen et al., 2013). The 5-HTTLPR alleles are considered either short or long with the most 
common variant of the short allele consisting of fourteen repeat sequences and the most 
common long allele consisting of sixteen repeats (Smolen et al., 2013). A bivariate indicator was 
constructed to identify any short (fourteen) repeat polymorphisms. 
 
Monoamine Oxidase A Gene. The monoamine oxidase A upstream VNTR gene is 
located on the X chromosome and contains a 30 bp VNTR in 5’ regulatory region of the gene 
(Smolen et al., 2013). Allele repeats range from two to five and are typically dichotomized where 
two or three repeats are considered “low expressing” or “not active” and 3.5, four or five repeats 
are considered “high expressing” or “active” (Smolen et al., 2013). An indicator variable was 
created to indicate any active repeats. Based on the X chromosome location of the MAOA gene, 
this indicator represents any active MAOA repeats on either allele A or allele B or both for 
females, while for men this indicator represents active MAOA on allele A only. 
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Reliability of Genetic Sampling. Although genetic sample processing was done under 
reliable conditions, an assessment of quality has been previously conducted (Smolen et al., 
2013). During collection a random sample of 58 participants provided two samples one to two 
weeks apart. The samples were used to establish test-retest reliability. Kappa values suggested 
good to excellent reliability with percent agreement ranging from 84% to 97% per candidate 
gene. All genetic candidates included in the proposed analysis had agreement of 88% or higher 
(Smolen et al., 2013). 
 
Social Factors 
 Proposed social factors include social and family support. Prior Add Health studies have 
combined parent, adult, teacher, and peer support into one social support scales (Beaver, 
Boutwell, & Barnes, 2014; Kort-Butler, 2010; Rawana, 2013; Wight, Botticello, & Aneshensel, 
2006). However, these two constructs were hypothesized separately, thus separate family 
support and social support scales were constructed. 
A recent study used a subset of Add Health to the development of the Battery of 
Adolescent Measures. The study used several measurement techniques and 88 items to create 
19 assessment scales. The scales cover topics related to families and parents, peers and 
sexuality, schools, and neighborhoods (Benson & Faas, 2014). Both the social and family 
support scales were based off of subscales of the Battery of Adolescent Measures. 
 
Family Support. The Parent-Family Connectedness factor within the Battery of 
Adolescent Measures is comprised of three subscales; family understanding, maternal warmth, 
and paternal warmth. Items from these three subscales were used to create a two-factor family 
support scale (see table 3). The original family understanding subscale of the Battery of 
Adolescent Measures consisted of three items; however, only one item measures how much the 
individual feels that their family understands them while the other two items measure how much 
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the individual feels that they and their family have fun together and how much they feel their 
family pays attention to them. For the purpose of this study, the subscale was renamed from 
family understanding to family connectedness to better reflect the content of the three items. 
Each item was measured on a five-point Likert scale ranging from “not at all” to “very much”. 
The original study reported a Cronbach’s alpha of .80 and factor loadings of all .81 and higher 
for each gender separately as well as the combined sample (Benson & Faas, 2014). 
 Originally two sub-scales, items from the maternal warmth and paternal warmth scales 
were combined to create one parent warmth scale in order to account for single parent 
households. Both maternal and paternal warmth were assessed using five items that were 
asked separately for each parent (see table 3). The items were all measured on a five-point 
Likert scale with the first three items ranging from “strongly disagree” to “strongly agree” and the 
last two items ranging from “not at all” to “very much”. The highest score between mothers and 
fathers on each item was used to create one parent warmth scale. 
 
Social Support. While the Battery of Adolescent Measures contains several peer related 
sub-scales, the majority where focused on sexual health and did not fit the proposed construct 
of social support. However, the participants were school aged at wave I, and thus school setting 
would be expected to be a large factor in their perceived social support. To incorporate the 
school setting, a social support scale was build using the Battery’s school connectedness scale 
with the addition of two items to assess friendship connections and perceived social acceptance 
(see table 3). The original school connectedness sub-scale consisted of five factors; however, 
“the teachers at your school treat students fairly” was removed both to conceptually focus on 
peers and social relationships, but also due to low factor loadings in the original scale 
assessment. Two items, “how much do you feel that your friends care about you” and “you feel 
socially accepted” was added as a second proposed factor titled friend connectedness. These 
were added to assess friends and social connections beyond the school atmosphere. These six 
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items were all measured on five-point Likert scales with most ranging from “strongly disagree” to 
“strongly agree”, with the exception of “how much do you feel that your friends care about you,” 
which ranged from “not at all” to “very much”. 
 
Table 3. Support Scale Items 
Scale Wave I Items 
Family Support  
   Parent Warmth 1. Most of the time, your {mother or father} is warm and loving 
toward you. 
2. You are satisfied with the way your {mother or father} and you 
communicate with each other. 
3. Overall you are satisfied with your relationship with your {mother 
or father}. 
4. How close do you feel to your {mother or father}? 
5. How much do you think your {mother or father} cares about you? 
   Family    
   Connectedness 
6. How much do you feel that people in your family understand you? 
7. How much do you feel that you and your family have fun 
together? 
8. How much do you feel that your family pays attention to you? 
Social Support  
   School  
   Connectedness 
1. You feel close to people at your school. 
2. You feel like you are a part of your school. 
3. You are happy to be at your school. 
4. You feel safe in your school. 
   Friend  
   Connectedness 
5. How much do you feel that your friends care about you? 
6. You feel socially accepted. 
 
  
Both family and social support scales were found to have good fit and reliability with 
gender samples. CFA results of the family support scale are displayed in appendix C (figure C1 
and figure C2) and the social support scale are displayed in appendix D (figure D1 and figure 
D2). Among females, evaluation of the family support scale resulted in a Cronbach’s alpha of 
.92 and the follow CFA fit indices: Χ2(df=19)=435.04, p<.001; RMSEA=.06; CFI=.95; and 
SRMR=.04. Results were similar among the males with a Cronbach’s alpha of .90 and the 
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following fit indices: Χ2(df=19)=583.46), p<.001; RMSEA=.08; CFI=.90; SRMR=.06. Results for 
the social support scale were almost identical between the genders with the following fit indices 
for females: Χ2 (df=8)=81.54, p<.001; RMSEA=.04; CFI=.98; SRMR=.02; and the following fit 
indices for males: Χ2(df=8)=47.80, p<.001; RMSEA=.03; CFI=.99; SRMR=.02. Cronbach’s alpha 
values were .90 and .84 for females and males respectively. 
 
Personality Factors 
 Based on the person-environment transaction theory, personality is predicted to change 
over time, thus personality was assessed at both wave I and wave IV. However, due to the 
available items these measure slightly vary and thus were treated as separate constructs.   
At wave I, personality scales based on the Five Factor Model or the “Big Five” were 
previously been constructed and evaluated (Young & Beaujean, 2011). These scales were 
creating used a lexical method to identify twenty-one personality items. Factor analysis 
techniques were then used with the entire sample split in half; half was used for EFA purposes 
and the other half was used in CFA with maximum likelihood estimates (Young & Beaujean, 
2011). After several rounds of item reduction a final thirteen-item, a three-factor solution was 
derived and found to have good fit via CFA fit indices (CFI=.97, RMSEA=.08, SRMR=.02) 
(Young & Beaujean, 2011). The three factors represented traits of conscientiousness, 
neuroticism, and extroversion. Personality traits previously linked to the ADHD/ED comorbidity 
included novelty seeking, self-directedness, obsessive compulsiveness, and perfectionism 
(Fernández-Aranda et al., 2013). Based on the conceptual similarities of these hypothesized 
traits with available scales, the conscientiousness and neuroticism scales were included as 
potential underlining mechanisms (see table 4). All wave I items were measured on a five-point 
Likert scale ranging from “strongly agree” to “strongly disagree”. For clarity, neuroticism and 
conscientiousness scales at wave I are referred to as adolescent neuroticism and adolescent 
conscientiousness. 
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Table 4. Personality Scale Items  
Scale Wave I Items (Adolescent) Wave IV Items (Adult) 
Neuroticism • You have a lot of good qualities  
• You have a lot to be proud of  
• You like yourself just the way you are  
• You feel like you are doing everything 
just about right  
• You feel socially accepted  
• You feel wanted and loved  
• I have frequent mood 
swings 
• I am relaxed most of the 
time 
• I get upset easily 
• I seldom feel blue 
Conscientiousness • When you have a problem to solve, one 
of the first things you do is get as 
many facts about the problem as 
possible 
• When you are attempting to find a 
solution to a problem, you usually try 
to think of as many different ways to 
approach the problem as possible  
• When making decisions, you generally 
use a systematic method for judging 
and comparing alternatives 
• After carrying out a solution to a 
problem, you usually try to analyze 
what went right and what went wrong 
• I get chores done right 
away  
• I often forget to put things 
back in their proper place  
• I like order 
• I make a mess of things 
 
 
 
Wave IV included items of a similar nature to measure the same personality constructs, 
however item wording varied. These scales are also based on the Five Factor or Big Five 
personality model (Harris, 2011; Harris et al., 2009). As with wave I, all items were scored on a 
five-point Likert scale ranging from “strongly agree” to “strongly disagree”. Previous predictive 
validity was found in that all the wave IV items had high pattern coefficients on their intended 
factors via CFA methods (Young & Beaujean, 2011). Specific items of the conscientiousness 
and neuroticism scales are listed in table 4. For clarity purposes, the wave IV neuroticism and 
conscientiousness scales are referred to as adult neuroticism and adult conscientiousness. 
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 One CFA model was constructed for all personality scales. Results are displayed in see 
appendix E (figure E1 and figure E2). Good fit was demonstrated for both the female and male 
samples. Among females, CFA resulted in the following fit indices: Χ2(df=113)=733.66, p<.001; 
RMSEA=.03; CFI=.95; and SRMR=.03. Results were similar among the males with the following 
fit indices: Χ2(df=113)=488.20, p<.001; RMSEA=.03; CFI=.96; SRMR=.03. As expected, 
conscientiousness at wave I was positively correlated with conscientiousness at wave IV, 
neuroticism at wave I was positively correlated with neuroticism at wave IV, and each 
assessment of conscientiousness was negatively correlated with each assessment of 
neuroticism. After CFA, negatively worded items were reversed for scale sum scoring. 
 
Cognitive Factors 
 Predicted cognitive underlying factors based on the Research Domain Criteria Matrix 
include both cognitive control and working memory. 
 
Cognitive Control. Cognitive control is conceptualized as impulsivity, disinhibition, and 
externalization and is associated with various areas of the prefrontal cortex (National Institutes 
of Mental Health, n.d.). In order to measure this construct, an assessment of impulsivity was 
selected as a proxy to measure cognitive and motor control. Wave III items were selected to 
align with items of the Barratt Impulsiveness Scale (BIS), one of the most widely used 
assessments of impulsivity (Fossati, Di Ceglie, Acquarini, & Barratt, 2001; Stanford et al., 2009). 
The BIS has a three second-order factor structure consisting of cognitive impulsiveness (i.e., 
making quick decisions), motor impulsiveness (i.e., acting without thinking), and non-planning 
impulsiveness (i.e., a lack of future thinking) (Barratt, 1985; Stanford et al., 2009). Six first order 
factors are as follows: cognitive impulsiveness (attention and cognitive instability), motor 
impulsiveness (motor and perseverance), non-planning impulsiveness (self-control, cognitive 
complexity) (Stanford et al., 2009). Higher scores on the BIS have been correlated with 
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substance use disorders, mood disorders, bipolar disorder, suicidal ideation, and serotonin and 
MAO genetic polymorphisms (Stanford et al., 2009). However, BIS scores were not associated 
with attention in laboratory experiments (Stanford et al., 2009), suggesting a distinction between 
BIS measured impulsivity and attention as conceptualized as ADHD. Through extensive 
examinations the thirty-item BIS scale has been found to be both reliable and valid (Barratt, 
1965; Fossati et al., 2001; Patton & Stanford, 1995; Reid, Cyders, Moghaddam, & Fong, 2014; 
Reise, Moore, Sabb, Brown, & London, 2013; Stanford et al., 2009). Based on the content of the 
original items and available Add Health items, the non-planning impulsiveness factor was not 
included in the constructed cognitive control measure. The original items for the cognitive 
impulsiveness and motor impulsiveness factors are listed in table 5. 
Six items were selected from wave III to reflect the cognitive impulsiveness and motor 
impulsiveness higher order factors (see table 5). All items were measured on five-point Likert 
scales either ranging from “not true” to “very true” or “strongly agree” to “strongly disagree” with 
the exception of the following item, “you had trouble keeping your mind on what you were doing 
during the past seven days” which was assessed on a four-point scale ranging from 
“never/rarely” to “most of the time/all of the time”. The constructed scale was based on the two 
higher order factors, as opposed to the four first order factors, based on the limitations of 
available questions. 
As with all other scale assessments, CFA results demonstrated good fit for both samples 
(see appendix F, figure F1 and figure F2.). Among females, CFA of the two-factor scale resulted 
in the following fit indices: Χ2(df=8)=72.01, p<.001; RMSEA=.04; CFI=.97; and SRMR=.02. 
Almost identical results were obtained with the male sample: Χ2 (df=8)=41.18, p<.001; 
RMSEA=.03; CFI=.98; SRMR=.02. Cronbach’s alpha estimates of the six items were .68 and 
.78 for females and males respectively. 
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Table 5. Original BIS-11 Items and Cognitive Control Scale Items 
Scale Original BIS-11 Items  Wave III Items 
Cognitive 
Impulsiveness 
  
Attention 1. I don’t ‘‘pay attention” 
2. I concentrate easily 
3. I ‘‘squirm” at plays or lectures 
4. I am a steady thinker 
5. I am restless at the theater or 
lectures 
1. I change my interest a lot, 
because my attention often 
shifts to something else 
2. You had trouble keeping your 
mind on what you were doing, 
during the past seven days 
Cognitive Instability 6. I have ‘‘racing” thoughts 
7. I change hobbies 
8. I often have extraneous 
thoughts when thinking 
Motor 
Impulsiveness 
  
Motor 1. I do things without thinking 
2. I make-up my mind quickly 
3. I am happy-go-lucky 
4. I act ‘‘on impulse”  
5. I act on the spur of the 
moment 
6. I buy things on impulse 
7. I spend or charge more than 
I earn 
1. I sometimes get so excited that 
I lose control of myself 
2. I often do things based on how 
I feel at the moment 
3. Do you agree or disagree that 
when making a decision, you 
go with your “gut feeling” and 
don’t think much about the 
consequences of each 
alternative? 
4. Do you agree or disagree that 
in social situations, you tend 
not to follow the crowd, but 
instead behave in a way that 
suits your mood at the time? 
Perseverance 8. I change jobs 
9. I change residences 
10. I can only think about one 
thing at a time 
11. I am future oriented 
 
 
Working Memory. Working memory, a type of short-term memory, is responsible for 
temporarily storing and manipulating, or processing new information (Baddeley, 1992). This was 
measured via a memory assessment test at wave IV. Participants were asked to repeat a string 
of numbers backwards. The strings began with two numbers and grew in length, up to eight 
numbers. The interviewer reported a binary variable indicating whether the string was correctly 
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repeated backwards. The constructed memory variable indicates the total number of correct 
sequences repeated backwards. 
 
Psychiatric Factors 
 Psychiatric factors were measured via items from wave IV.  The wave IV psychiatric 
items assess lifetime diagnoses. Although there is bias in that a participant may have had an 
undiagnosed psychiatric illness, using lifetime diagnoses at the most recent wave helps 
minimizing bias related to diagnoses made later in time (i.e., in between wave III and wave IV). 
 
Depression and Anxiety Disorders. Lifetime clinical depression was measured via a 
yes/no indicator variable based on the following question, “Has a doctor, nurse or other health 
care provider ever told you that you have or had depression?” Similarly clinical anxiety or panic 
disorder was measured via a yes/no indicator variable based on, “Has a doctor, nurse or other 
health care provider ever told you that you have or had an anxiety or panic disorder?” 
 
Childhood Abuse. Experiences of childhood sexual and physical abuse were assessed 
at wave III. Childhood sexual abuse was assessed via the following question: “By the time you 
started 6th grade, how often had your parents or other adult caregivers touched you in a sexual 
way, forced you to touch him or her in a sexual way, or forced you to have sexual relations?” 
Physical abuse was assessed with the following questions: “By the time you started 6th grade, 
how often had your parents or other adult caregivers slapped, hit, or kicked you?” Participants 
were considered as having experienced childhood abuse if either of these events were reported 
as happening even once. These same questions were also asked at wave IV with the timeframe 
of before age eighteen as opposed to before sixth grade; however, only the wave III 
assessment was included in this study in order to better represent these experiences in 
childhood as opposed to adolescents when ADHD or an ED may have already developed. 
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There is an assessment of lifetime diagnosed PTSD at wave IV, however that indicator was 
excluded, as it does not differentiate sexual and physical abuse experiences from PTSD as a 
result of other, non-abuse situations. 
 
Alcohol and Substance Abuse Disorders. Wave IV contains several pre-constructed 
variables, two of which include lifetime alcohol abuse/ dependency based on DSM IV criteria 
and lifetime other drug abuse/ dependency based on DSM IV criteria (APA, 2000). The alcohol 
abuse/ dependency and drug abuse dependency variables identify individuals with no history of 
abuse/dependency, a history of abuse, a history of dependency with no physiological 
symptoms, a history of dependency with physiological symptoms, and a history of dependency 
with clustering of three dependency symptoms in a twelve-month period. Specific items that 
were used in the construction of these variables are listed in table 6. Each variable was 
dichotomized to indicate a history of any alcohol abuse/ dependency and any drug abuse/ 
dependency. As the measures assess both abuse and dependency, they are referred to as 
indicators of alcohol and substance use disorders. The substance use disorder classification 
does not include abuse or dependency related to marijuana. 
Good internal consistency (Cronbach’s alpha=.88) and significant correlations were 
found among the items used in the construction of these pre-calculated variables (p<.001). In 
order to evaluate the validity of these variables, comparisons were made between the 
dichotomized alcohol and drug indicators with following wave III variables: 1) “In the past 12 
months have you attended a drug-abuse or alcohol-abuse treatment program?”; 2) “In the past 
12 months have you received psychological or emotional counseling?” Both alcohol use 
disorders and substance use disorders were significantly correlated with both wave III items 
(p<.001). 
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Table 6. Alcohol and Substance Use Disorder Indicator Construction 
Wave IV Items 
Alcohol Use Disorder 
Abuse 
• How often has your drinking interfered with your responsibilities at work or school? 
• How often have you been under the influence of alcohol when you could have gotten yourself or others 
hurt, or put yourself or others at risk, including unprotected sex? 
• How often have you had legal problems because of your drinking, like being arrested for disturbing the 
peace or driving under the influence of alcohol, or anything else? 
• How often have you had problems with your family, friends, or people at work or school because of your 
drinking? 
• Did you continue to drink after you realized drinking was causing you problems with family, friends, or 
people at work or school? 
Dependency 
• Have you ever found that you had to drink more than you used to in order to get the effect you wanted? 
• Has there ever been a period when you spent a lot of time drinking, planning how you would get alcohol, or 
recovering from a hangover? 
• Have you often had more to drink or kept drinking for a longer period of time than you intended? 
• Has there ever been a period of time when you wanted to quit or cut down on your drinking? 
• When you decided to cut down or quit drinking, were you able to do so for at least one month? 
• During the first few hours of not drinking, do you experience withdrawal symptoms such as the shakes, 
feeling anxious, trouble getting to sleep or staying asleep, nausea, vomiting, or rapid heartbeats? 
• Have you ever continued to drink after you realized drinking was causing you any emotional problems (such 
as feeling irritable, depressed, or uninterested in things or having strange ideas) or causing you any health 
problems (such as ulcers, numbness in your hands/feet or memory problems)? 
• Have you ever given up or cut down on important activities that would interfere with drinking like getting 
together with friends or relatives, going to work or school, participating in sports, or anything else? 
Substance Use Disorder 
Abuse 
• How often has your {favorite drug*} use interfered with your responsibilities at work or school? 
• How often have you been under the influence of your {favorite drug*} when you could have gotten yourself 
or others hurt, or put yourself or others at risk, including unprotected sex? 
• How often have you had legal problems because of your {favorite drug*} use, like being arrested for 
disturbing the peace or anything else? 
• How often have you had problems with your family, friends, or people at work or school because of your 
{favorite drug*} use? 
• Did you continue to use your {favorite drug*} after you realized using it was causing you problems with 
family, friends, or people at work or school? 
Dependency 
• Have you ever found that you had to use more {favorite drug*} use than you used to in order to get the 
effect you wanted? 
• Has there ever been a period when you spent a lot of time using {favorite drug*}, getting it, or getting over 
its effects? 
• Have you often had to use more {favorite drug*} or used {favorite drug*} longer than you intended? 
• Has there ever been a period of time when you wanted to quit or cut down on your use of {favorite drug*}? 
• When you decided to cut down or quit using {favorite drug*}, were you able to do so for at least one month? 
• During the first few hours of not using {favorite drug*}, do you experience one or more withdrawal symptoms 
such as craving {favorite drug*}, feeling depressed, anxious, restless or irritable, having trouble 
concentrating, feeling tired or weak, having trouble sleeping, or a change in appetite? 
• Have you ever continued to use {favorite drug*} after you realized using {favorite drug*} was causing you 
any emotional problems (such as feeling depressed or empty, feeing irritable or aggressive, feeling 
paranoid or confused, feeling anxious or tense, being jumpy or easily startled) or causing you any health 
problems (such as heart pounding, headaches or dizziness, or sexual difficulties)? 
• Have you ever given up or cut down on important activities that would interfere with your {favorite drug*} 
use like getting together with friends or relatives, going to work or school, participating in sports, or anything 
else? 
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Demographic Variables 
Demographic variables included race, grade at wave I, parent education level, annual 
family income, age at wave III, education attainment by wave III, and individual income at wave 
III. Race and grade were both self-reported by the participant during the wave I interview. Race 
was categorized as White (Non-Hispanic), Black (Non-Hispanic), Hispanic, Asian, or another 
race, and grade continuously ranged from seventh grade through twelfth grade. Grade was 
unknown among a small portion of participants either because the participant did not know his 
or her grade or because his or her school did not use standard grade levels. 
A subset of the participants’ parents was interviewed at wave I. Parent education level 
and annual family income at wave I were reported by the parent. Education level of the 
interviewed parent was categorized as less than high school, high school graduate, some 
college, and college graduate or higher. Annual family income was categorized as less than 
$24,000, $24,000 to $44,999, and $45,000 or higher. Both parent education level and annual 
family income information is unknown for a portion of participants either because the parent was 
not interviewed, refused to respond, or did not know. There are major concerns to note with 
these two variables. Since not all parents were interviewed and some of those that were did not 
answer these questions, there are a high proportion of unknowns within each variable. Thus, 
while distributions and results of gender comparisons are reported, both must be considered 
within the context of a large portion of unknowns for these variables, and thus might not be 
accurate. 
Age at wave III was calculated by the participants’ interviewer and was categorized into 
ages eighteen through twenty, twenty-one through twenty-three, and twenty-four through 
twenty-eight. Educational attainment was dichotomized into having gradated high school by 
wave III or not. Lastly, individual income at wave III was self-reported by the participant and 
categorized as less than $4,800 a year, $4,800 to $12,999 a year, and $13,000 or higher. 
Individual income is unknown for a large portion of participants due to either refusal to answer or 
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the participant reporting that they did not know. There are also concerns regarding this variable 
to consider. The variable assessed the individual’s personal income and not household income.  
With ages ranging from eighteen to twenty-eight some participants may have significant 
financial support from a parent or guardian, or potentially a significant other. Moreover, some of 
the participants were still in some form of school, limiting their ability to have an income as high 
as other participants not in school. 
 
Participant Characteristic Profile 
 Several additional variables were collected in order to address the sub-RQs of aim two.  
These variables were only constructed for males and include demographic factors, physical 
health factors, and behavioral health factors. 
 
Demographic Factors. In addition to the other basic demographic variables described 
above, an indicator of perceived intelligence was included. The original item, “compared with 
other people your age, how intelligent are you” was measured on a six-point Likert scale ranging 
from “moderately below average” to “extremely above average”. The item was dichotomized as 
an indicator of perceiving oneself as having above average intelligence. 
 
Physical Health Factors. Physical health factors included physical activity, performance 
enhancing substance or steroid use, high cholesterol, hypertension, body mass index, and 
obesity. Physical activity was measured as the number of times the participant reported being 
active in the past week. Specifically, at wave I, the participant was asked, “During the past 
week, how many times did you…go rollerblading, roller-skating, skate-boarding, or bicycling; 
play an active sport such as baseball, softball, basketball, soccer, swimming, or football; 
exercise such as jogging, walking, doing karate, jumping rope, doing gymnastics or dancing.” At 
wave III, the participants were asked the same question for the following activities: bicycle, 
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skateboard, dance, hike, hunt, or yard work; roller blade, roller skate, downhill ski, snow board, 
play racquet sports, or aerobics; participate in strenuous team sports such as football, soccer, 
basketball, lacrosse, rugby, field hockey, or ice hockey; participate in individual sports such as 
running, wrestling, swimming, cross-country skiing, cycle racing, or martial arts; participate in 
gymnastics, weight lifting, or strength training; or play golf, go fishing or bowling, or play softball 
or baseball. For each wave a sum variable was created as the number of times the participant 
reported being active. 
There are several limitations to note with regards to these two variables. First, the 
measures only assess activity in the prior week, which may not be representative of an average 
week. Secondly, the measure is the sum of times active, as opposed to the number of active 
days or number of times active for a specific amount of time or intensity. This means that each 
occurrence of activity may not have been at an intensity level or duration long enough for 
physical health benefits. 
Use of a legal performance-enhancing substance for athletics, such as Creatine, 
Monohydrate, or Andro, anabolic steroids or other illegal performance enhancing substances 
was measured as any use in the past year. High cholesterol and hypertension were assessed at 
wave IV. Indicators represent the participant having been told by a doctor or health care 
provider that he or she had either condition. Continuous measures of body mass index and 
obesity were constructed using height and weight. At wave I the participants were asked to self-
report their height and weight. Self-reported wave I body mass index was age adjusted. At wave 
III, the interviewer measured height and weight. An Indicator of obesity at each wave was 
constructed as having a body mass index of thirty or higher. 
 
Behavioral Health Factors. Behavioral health factors included mental health care 
utilization, delinquent behavior, and sexual behaviors. Mental health care utilization was 
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measured as having self-reported being in psychological counseling or in alcohol abuse or drug 
abuse treatment within the past twelve months at wave III. 
With regards to delinquent behaviors, Add Health included a delinquency scale at wave 
I. Participants were asked how often in the past twelve months did they do any delinquent 
behaviors from a list of fifteen behaviors. The list included: 1) paint graffiti or signs on someone 
else’s property or in a public place, 2) deliberately damage property that didn’t belong to you, 3) 
lie to your parents or guardians about where you had been or whom you were with, 4) take 
something from a store without paying for it, 5) get into a serious physical fight, 6) hurt someone 
badly enough to need bandages or care from a doctor or nurse, 7) run away from home, 8) drive 
a car without its owner’s permission, 9) steal something worth more than $50, 10) go into a 
house or building to steal something, 11) use or threaten to use a weapon to get something 
from someone, 12) sell marijuana or other drugs, 13) steal something worth less than $50, 14) 
take part in a fight where a group of your friends was against another group, or 15) act loud, 
rowdy, or unruly in a public place. All items were measured on a four-point scale ranging from 
“zero times” to “five or more times” and a continuous delinquency sum score was constructed. 
Arrest history was also included within delinquent behavior, measured as having ever been 
arrested, regardless of the crime or outcome, by wave IV. 
Lastly, sexual behaviors and orientation were assessed at wave IV. Sexual behavior 
variables included age at first sex (vaginal or anal) and number of lifetime sex partners for all 
types of sexual activity. A sexual orientation variable was also included indicating if the 
participant reported being “100% homosexual” or “mostly homosexual/somewhat attracted to 
opposite sex” versus any other form of sexual orientation. 
 
Analytical Plan 
Statistical techniques varied by aim and RQ but included chi-square tests, Fisher’s exact 
tests, independent sample t-tests, simple linear regressions, simple logistic regressions, and 
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structural equation modeling. While the data is longitudinal and variables were selected from 
multiple waves, cross sectional analytical methods were used. Proper sample weights were 
applied to all analyses and all procedures were run in either SAS 9.4 or MPlus 7. 
First, descriptives was gathered as well as chi-square test comparisons by gender for 
each demographic variable. Several demographic categorical variables contained multiple 
categorical outcomes (i.e., more than two). In these cases, an initial chi-square was run for the 
entire categorical variable. If the initial test revealed significant differences at an alpha of 0.10, 
separate chi-square tests were then run for each category within the variable. 
Next, descriptives were assessed as well as chi-square comparisons by gender for 
neither disorder, any ADHD, ADHD alone (i.e., no ED), any ED, ED alone (i.e., no ADHD), and 
comorbid ADHD/EDs. Simple logistic regressions were conducted for each gender with ADHD 
as a predictor of ED within gender. A regression was used for this step as opposed to a 
correlation analysis due to the inability to apply sample weight to correlations in SAS 9.4. 
Then, comparisons by gender and disorder status for each genetic, psychosocial, and 
psychiatric factor was conducted with either chi-square tests for categorical factors or 
independent sample t-tests for continuous factors when comparing by gender. Within each 
gender, regression analysis was used to compare females with neither disorder, ADHD alone, 
and ED alone to a reference category of females with comorbid ADHD/ED. 
Next, analyses were conducted for aim one among females. Based on the lack of 
previous investigations of the proposed underlying mechanism and the complexity of the 
proposed model, before testing the entire structural equation model (i.e., simultaneous 
investigation of the three hypotheses), each individual factor was tested separately via simple 
unadjusted logistic regressions to evaluate the relationship of that factor with the comorbidity. 
This technique addressed the first two RQs, which aimed to determine which risk regulator and 
genetic factors were independently associated with the comorbidity. The same regressions are 
also displayed for ADHD alone and ED alone outcomes as comparisons. 
 66 
Only factors that were significantly associated with the comorbidity on its own were 
retained for the structural equation model, with the exception of genetic factors. Despite issues 
related to multiple comparisons, this step was used solely to simplify the model to only 
potentially significant factors, thus any factors significant at an alpha level of .05 were retained. 
Regardless of independent logistic regression results, all genetic factors were retained for the 
full model due to the third RQ, which aims to investigate how the risk regulators impact the 
association between the genetic factors and the comorbidity, as well as for the third pathway 
investigating the direct link between the genetic factors and risk regulators. 
The structural equation model initially consisted of a partial mediation model where the 
psychosocial and psychiatric factors mediate the relationship between ADHD and EDs as well 
as mediate the relationship between the genetic factors and the comorbidity with genetic factors 
also being directly linked to the comorbidity. From the conceptual framework (see figure 2) the 
main paths of interest for this structural equation model are P4 through P6; specifically, the 
pathway from the genetic substrate directly to the comorbidity, the mediation pathway of the 
psychosocial and psychiatric risk regulators between ADHD and EDs, and the indirect pathway 
from the genetic substrate to the psychosocial and psychiatric risk regulators to the comorbidity. 
The mediation model meets the temporal criteria needed for mediation, where the mediator 
(psychosocial and psychiatric factors) occurs temporally after the predictor (genetic factors) and 
prior to the outcome (comorbid ADHD/ED) (MacKinnon & Fairchild, 2009; MacKinnon, Fairchild, 
& Fritz, 2007). Although some of the variables are measured in wave IV, after the 
measurements of ADHD and EDs, the constructs theoretically occur in the correct order or 
assess factors that are not expected to change over time, for example lifetime diagnoses. 
In MPlus 7, weighted least squares means and variance adjusted (WLSMV) was used to 
estimate the model due to the binary nature of the outcome (Proitsi et al., 2011). The same fit 
indices used to evaluate the CFA models, specifically the chi-square test of model fit, CFI, 
RMSEA, and WRMR were used to evaluate fit of the full structural equation model. Results of 
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the fit of the initial model with all retained factors as well as analysis of residuals, modification 
indices, and theoretical considerations were used to guide several rounds of model re-
specification. 
Lastly, aim two analyses were conducted among males. Descriptive of additional 
demographic, physical health, and behavioral health factors were assessed and compared 
across disorder status. Regressions were used to compare men with neither disorder, ADHD 
alone, and ED alone to a reference category of men with comorbid ADHD/ED. In order to 
determine the association of the underlying mechanism, simple unadjusted logistic regression 
models were constructed with individual comparisons of the association of each proposed 
factors with comorbidity ADHD/ED.  
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CHAPTER FOUR: RESULTS 
 
Participant Descriptive Statistics 
 Table 7 displays descriptive information regarding basic demographics for the female 
sample (n=6,289) and male sample (n=5,248). The racial distribution was similar for both 
genders with no significant differences. Racial distributions were as follows: among females, 
66.3% of participants reported that they were White (Non-Hispanic), 16.3% were Black (Non-
Hispanic), 11.2% were Hispanic, 3.5% were Asian, and 2.7% were of another race. In 
comparison, among males, 65.5% reported being White (Non-Hispanic), 15.5% were Black 
(Non-Hispanic), 11.9% were Hispanic, 3.8% were Asian, and 3.4% were of another race.   
There were no differences by gender, with regards to grade at wave I with the grade 
distribution being relatively evenly split for both genders. However, there were significant 
differences between genders regarding age at wave III (p<.001). Specifically, there were a 
higher proportion of females in the eighteen to twenty year old group (30.5% vs. 27.3%, p<.05), 
and a higher proportion of males in the twenty-four to twenty-eight year old group (20.3% vs. 
23.6%, p<.001). 
There were no differences between genders with regards to parent reported annual 
family income at wave I. Among females, 22.4% had an annual family income of less than 
$24,000, 24.4% had a family income of $24,000 to $44,999, 30.8% had a family income of 
$45,000 or higher, and family income was unknown for 22.3% of females. Similarly among 
males, 23.4% had an annual family income of less than $24,000, 25.1% had a family income of 
$24,000 to $44,999, 31.3% had a family income of $45,000 or higher, and family income was 
unknown for 20.1% of males. 
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Table 7. Sample Descriptive Statistics by Gender 
 
Females 
(n=6,289) 
Males 
(n=5,248) p-value 
Race 
     White (Non-Hispanic) 
     Black (Non-Hispanic) 
     Hispanic 
     Asian 
     Another Race 
66.3 (3,368) 
16.3 (1,442) 
11.2 (930) 
3.5 (384) 
2.7 (164) 
65.5 (2,851) 
15.5 (995) 
11.9 (849) 
3.8 (394) 
3.4 (159) 
.3872 
Grade at Wave I 
     7th
 
Grade 
     8th Grade 
     9th Grade 
     10th Grade 
     11th Grade 
     12th Grade 
     Unknown1 
17.9 (896) 
15.6 (872) 
17.0 (1,105) 
16.7 (1,188) 
14.5 (1,127) 
15.7 (972) 
2.5 (129) 
17.3 (689) 
16.9 (691) 
17.2 (948) 
15.1 (1,000) 
15.4 (1,024) 
15.9 (796) 
2.3 (100) 
.3009 
Parent Education Level2 
     Less than High School 
     High School Graduate 
     Some College 
     College Graduate or Higher 
     Unknown3 
14.8 (975) 
28.8 (1,606) 
15.9 (1,033) 
27.4 (1,800) 
13.0 (875) 
14.1 (686) 
27.3 (1,322) 
16.4 (946) 
30.7 (1,615) 
11.5 (679) 
.0529 
.4761 
.2122 
.6149 
.0088 
.0920 
Annual Family Income at Wave I2 
Less than $24,000 
$24,000 – $44,999 
$45,000 or Higher 
Unknown3 
22.4 (1,368) 
24.4 (1,497) 
30.8 (1,885) 
22.3 (1,539) 
23.4 (1,129) 
25.1 (1,291) 
31.3 (1,668) 
20.1 (1,160) 
.2630 
Age at Wave III 
     18 – 20 years old 
     21 – 23 years old 
     24 – 28 years old 
30.5 (1,596) 
49.2 (3,435) 
20.3 (1,258) 
27.3 (1,133) 
49.1 (2,880) 
23.6 (1,235) 
.0006 
.0111 
.9332 
.0001 
High School Graduate by Wave III 
     No 
     Yes 
43.8 (2,660) 
56.2 (3,629) 
51.2 (2,519) 
48.8 (2,729) 
<.0001 
Individual Income at Wave III 
     Less than $4,800 
     $4,800 – $12,999 
     $13,000 or Higher 
     Unknown3 
26.6 (1,665) 
24.0 (1,437) 
28.4 (1,869) 
21.1 (1,318) 
19.7 (1,040) 
21.9 (1,095) 
40.6 (2,180) 
17.8 (933) 
<.0001 
<.0001 
.0801 
<.0001 
.0025 
Notes: Weighted % (n) 
1Not in school at the time of the interview or no grade level reported 
2Self-reported by a parent at Wave I 
3Not reported or no parent interviewed 
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There was one significant difference in regards to the education level of the interviewed 
parent, with males having a higher portion of the parent having graduated from college or higher 
(30.7% vs. 27.4%, p<.01). However, these distributions, the non-significant result with annual 
income, and significant result with education level must be considered within the limitations 
related to these variables described above. 
Significant gender differences were found in regards to the participants’ educational 
attainment by wave III and personal income at wave III. Females were significantly more likely 
to have reported having graduated from high school by wave III (56.2% vs 48.8%, p<.0001); 
however on average, females had lower personal incomes at wave III. A significantly higher 
proportion of females reported a personal income of less than $4,800 annually (26.6% vs. 
19.7%, p<.0001), and a significantly higher proportion of males reported an income of $13,000 
or higher (40.6% vs. 28.4%, p<.0001). There was also a significant difference in the proportion 
of unknown with 21.1% of female incomes and 17.8% of male incomes unknown (p<.01). As 
described above, these results must be considered within the context of the limitations of this 
variable. 
 
Prevalence of ADHD, EDs, and Comorbid ADHD/ ED 
 Table 8 displays prevalence information stratified by disorder status. A total of 15.5% 
(n=921) of females and 27.5% (n=1,309) of males reported any ADHD. A total of 11.2% (n=656) 
of females and 23.4% (n=1,124) of males reported ADHD alone (i.e. no ED). As expected, the 
prevalence was significantly higher among males for both any ADHD and ADHD alone 
(p<.0001). The prevalence of any ED and ED alone (i.e., no ADHD) was 21.0% (n=1,298) and 
16.8% (n=1,033) among females and 10.9% (n=602) and 6.8% (417) among males, 
respectively.  
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Table 8. Descriptive Statistics of ADHD and ED by Gender 
 
Females 
(n=6,289) 
Males 
(n=5,248) p-value 
Neither Disorder 67.8 (4,335) 65.7 (3,522) .1158 
Any ADHD 
ADHD Alone 
15.5 (921) 
11.2 (656) 
27.5 (1,309) 
23.4 (1,124) 
<.0001 
<.0001 
Any Eating Disorder 
Eating Disorder Alone 
21.0 (1,298) 
16.8 (1,033) 
10.9 (602) 
6.8 (417) 
<.0001 
<.0001 
Logistic Regression of ADHD as a Predictor of ED 
[OR(95% CI)] 
1.53*** 
(1.25 – 1.87) 
1.70*** 
(1.28 – 2.26) - 
Comorbid ADHD/ED 
     Percent of people with ADHD with Comorbid ED 
     Percent of people with ED with Comorbid ADHD 
4.2 (265) 
27.4 (265) 
20.2 (265) 
4.1 (185) 
14.9 (185) 
37.7 (185) 
.8104 
- 
- 
Notes: Weighted % (n) 
*** p<.0001 
 
As expected the rates of both any ED and ED alone were significantly higher among 
females (p<.0001). Although there were differences in prevalence of each individual disorder, 
there was no difference in the rate of the comorbidity, with 4.2% (n=265) of the females 
reporting both ADHD and an ED compared with 4.1% (n=185) of males (p=.8104). Moreover, 
both females and males with ADHD were significantly more likely to also report an ED (females: 
OR: 1.53, 95% CI: 1.25-1.87; males: OR: 1.70, 95% CI: 1.28-2.26). 
More specifically, among the 921 females who reported having ADHD, 27.4% also 
reported an ED; and among the 1,298 females that reported having an ED, 20.2% also reported 
ADHD. In regards to males, 14.9% of the 1,309 males with ADHD also reported an ED, and 
37.7% of the males with an ED also reported ADHD. 
 
Prevalence of Genetic Factors 
 Table 9 displays descriptive statistics for the genetic factors by gender and table 10 
displays similar information by gender and disorder status (i.e., neither disorder, ADHD alone, 
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ED alone, or comorbid ADHD/ED). As can be seen in both tables, the rates of the specific 
repeat patterns of interest are displayed for each gene.  
 
Table 9. Genetic Genotype Descriptives by Gender 
 Females 
(n=6,289) 
Males 
(n=5,248) p-value 
Monoamine Oxidase A (MAOA) Active 
    Zero Active 
    One Active 
    Two Active 
14.4 (1,008) 
46.2 (2,942) 
39.5 (2,335) 
 -  
 -  
 -  
 
    Zero Active 
    One Active 
 - 
 -   
39.3 (2,130) 
60.7 (3,118) 
 
Any Active 85.6 (5,278) 60.7 (3,120) <.0001 
Dopamine Receptor 4 (DRD4) 7 Repeat 
    Zero 7 Repeats 
    One 7 Repeat 
    Two 7 Repeats 
63.2 (4,000) 
32.6 (2,022) 
4.2 (267) 
64.4 (3,461) 
31.5 (1,571) 
4.1 (216) 
 
Any 7 Repeats 36.8 (2,289) 35.6 (1,787) .2860 
Dopamine Transporter (DAT1) 9 Repeat 
    Zero 9 Repeats 
    One 9 Repeat 
    Two 9 Repeats 
58.1 (3,814) 
36.5 (2,134) 
5.4 (341) 
60.3 (3,241) 
33.7 (1,731) 
6.0 (276) 
 
Any 9 Repeats 41.9 (2,475) 39.7 (2,007) .0675 
Dopamine Transporter (DAT1) 10 Repeat 
    Zero 10 Repeats 
    One 10 Repeat 
    Two 10 Repeats 
5.8 (379) 
38.1 (2,251) 
56.0 (3,659) 
7.0 (329) 
35.1 (1,802) 
57.9 (3,117) 
 
Any 10 Repeats 94.2 (5,910) 93.0 (4,919) .0498 
Serotonin Transporter (5-HTTLPR) Short Repeats 
(14 Repeat) 
    Zero Short Repeats 
    One Short Repeat 
    Two Short Repeats 
34.4 (2,197) 
46.5 (2,865) 
19.1 (1,224) 
32.2 (1,756) 
49.2 (2,461) 
18.6 (1,026) 
 
Any Short Repeats 65.5 (4,089) 67.7 (3,487) .0873 
Notes: Weighted % (n) 
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 Table 9 displays the rates for the sequence being found on both alleles (two active/ two 
repeats), one but not the other allele (one active / one repeat), or it was not found on either 
allele (zero active / zero repeats). As an example with the DRD4 gene and the seven repeat, 
two repeats would equate to a genotype of seven / seven, one repeat would equate to either 
seven / not seven or not seven / seven, and zero repeats would equate to a genotype of not 
seven / not seven. Rates of the sequences of interest are also displayed as having any of the 
specific sequence on either allele. 
 As can be seen in table 9, there was a significant difference between the prevalence of 
any active MAOA between females and males (85.6% vs. 60.7%, p<.0001). This is as to be 
expected based on the fact that females have to chromosomes with which MAOA could possibly 
be active on, versus just one chromosome among the males. There was no difference in the 
prevalence of any seven repeats on the DRD4 gene with a rate of 36.8% among females and 
35.6% among males. Both the nine repeats and ten repeats on the DAT1 gene were borderline 
significantly different between genders. The difference for the nine repeat was above the 
significant level for DAT1 with a rate of 41.9% among females and 39.7% among males 
(p=.0675), while the difference with regards to the ten repeat was just at the significance with 
prevalence of 94.2% among females and 93.0% among males (p=.0498).  Lastly there were no 
differences in the rate of any short repeats on the serotonin transporter with a rate of 65.5% 
among females and 67.7% among males (p=.0873). 
Table 10 displays the prevalence of each genetic factor by gender and disorder status, 
and results of logistic regression models for each status compared to comorbid ADHD/ED. 
There were just a few very slight differences by disorder status. Among these slight differences 
is the rate of any short 5-HTTLPR repeats between females with neither disorder (64.9%) and 
females with ED alone (64.8%) compared to females with comorbid ADHD/ED (73.1%). Both 
females with neither disorder and females with ED alone were just barely significantly less likely 
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to have any short repeats (Neither: OR: 0.68, 95% CI: 0.48-0.98, p=.0375; ED alone: OR: 0.68, 
95% CI: 0.47-0.99, p=.0467). 
The rate of any DRD4 seven repeats was slightly different between males with ADHD 
alone (34.2%) compared to males with comorbid ADHD/ED (43.4%); specifically, males with 
ADHD alone were slightly less likely to have any seven repeats (OR: 0.68, 95% CI: 0.47-0.98, 
p=.0363). The rate of any DAT1 nine repeats were slightly different between males with neither 
disorder (38.4%) compared to males with comorbid ADHD/ED (50.0%); specifically, males with 
neither disorder were slightly less likely to have any nine repeats (OR: 0.63, 95% CI: 0.40-0.98, 
p=.0416). Lastly, although not significantly different, males with ADHD only seemed to have 
lower rates of the DAT1 nine repeat (37.7%) compared to males with comorbid ADHD/EDs 
(50.0%, p=.0554). 
 
Table 10. Genetic Genotype Descriptives by Gender and Disorder Status 
Disorder Status 
(n) 
Any MAOA 
Active 
Any DRD4 
7 repeats 
Any DAT1 
9 repeats 
Any DAT1 
10 repeats 
Any 5-HTTLPR 
short repeats 
Females 
Neither Disorder  
(n=4,335) 
85.8 (0.8) 35.9 (1.0) 41.2 (1.1) 94.1 (0.5) 64.9* (1.2) 
ADHD Alone  
(n=656) 
86.2 (1.7) 39.4 (2.6) 41.7 (2.3) 94.9 (1.1) 67.6 (2.5) 
ED Alone  
(n=1,033) 
84.4 (1.5) 38.8 (1.9) 44.2 (2.1) 93.6 (0.9) 64.8* (1.7) 
Comorbid ADHD/ED 
(n=265) 
86.2 (2.8) 37.5 (3.9) 45.1 (3.9) 95.6 (1.4) 73.1 (3.4) 
Males 
Neither Disorder  
(n=3,522) 
60.5 (1.1) 35.2 (1.0) 38.4* (1.3) 93.5 (0.7) 67.5 (1.2) 
ADHD Alone  
(n=1,124) 
61.5 (1.9) 34.2* (1.8) 42.2 (2.0) 91.6 (1.1) 68.1 (1.8) 
ED Alone 
(n=417) 
58.4 (3.4) 38.5 (3.4) 37.7 (3.4) 92.6 (2.0) 68.7 (3.9) 
Comorbid ADHD/ED  
(n=185) 
64.2 (5.1) 43.4 (4.4) 50.0 (5.5) 92.3 (2.5) 67.5 (5.5) 
Notes: Weighted % (SE) 
* p<.05 compared to Comorbid ADHD/ED 
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Prevalence of Psychosocial and Psychiatric Mechanisms 
 Table 11 displays descriptive statistics for all psychosocial and psychiatric factors. There 
were many gender differences found. Specifically, females had significantly higher scores on 
the adolescent neuroticism, adult neuroticism, adult conscientiousness, and cognitive control 
scales, as well as higher rates of major depression and anxiety disorders (p<.0001). 
Conversely, females had significantly lower scores on the family support scale as well as lower 
rates of both alcohol and substance use disorders (p<.0001). There were no gender differences 
in regards to social support, adolescent conscientiousness, results of the memory task, or rates 
of having experienced childhood abuse. 
 
Table 11. Psychosocial and Psychiatric Risk Regulators Descriptives by Gender 
 
All 
Females 
(n=6,289) 
All 
Males 
(n=5,248) 
p-value 
Psychosocial [weighted mean (SE)]    
 Social 
    Family Support (SR1: 10 – 14) 
    Social Support (SR1: 7 – 30) 
33.3 (0.1) 
23.3 (0.1) 
34.2 (0.1) 
23.4 (0.1) 
<.0001 
.7333 
 
 Personality 
    Adolescent Neuroticism (SR1: 5 – 25) 
    Adolescent Conscientiousness (SR1: 4 – 20) 
    Adult Neuroticism (SR1: 4 – 20) 
    Adult Conscientiousness (SR1: 4 – 20) 
9.9 (0.1) 
15.1 (0.1) 
11.0 (0.1) 
14.8 (0.1) 
8.9 (0.1) 
15.2 (0.1) 
9.9 (0.1) 
14.3 (0.1) 
<.0001 
.3067 
<.0001 
<.0001 
 
 Cognitive 
    Cognitive Control (SR1: 6 – 29) 
    Memory (SR1: 0 – 7) 
19.7 (0.1) 
4.1 (0.0) 
18.5 (0.1) 
4.2 (0.1) 
<.0001 
.0607 
 
Psychiatric [weighted % (SE)]    
    Major Depression 
    Anxiety Disorder 
    Alcohol Use Disorder 
    Substance Use Disorder 
    Childhood Abuse 
22.7 (1.0) 
18.0 (0.8) 
22.5 (1.0) 
6.7 (0.5) 
37.6 (1.1) 
10.3 (0.7) 
8.1 (0.6) 
32.3 (1.2) 
9.5 (0.6) 
37.5 (1.1) 
<.0001 
<.0001 
<.0001 
<.0001 
.9655 
Notes: 1Possible Scale Scores 
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 Table 12 displays differences in the underlying mechanism by disorder status among 
females. Females with comorbid ADHD/ED had significantly lower scores on both the family and 
social support scales as compared to females with neither disorder and females with ED alone. 
Compared to all other categories, females with the comorbidity had higher scores on the 
adolescent neuroticism scale, and there were no differences with regards to adolescent 
conscientiousness. At wave IV, compared to females with neither disorder and females with ED 
alone, females with the comorbidity had significantly higher adult neuroticism scores and lower 
adult conscientiousness scores. Females with comorbid ADHD/ED had significantly lower 
cognitive control scores and higher rates of all psychiatric factors as compared to all other 
groups, with the except of alcohol use disorders. 
 
Table 12. Psychosocial and Psychiatric Risk Regulators Descriptives by Disorder Status 
among Females (n=6,289) 
 Neither 
Disorder 
(n=4,335) 
ADHD 
Alone 
(n=656) 
ED 
Alone 
(n=1,033) 
Comorbid 
ADHD/ED 
(n=265) 
Psychosocial [weighted mean (SE)]     
 Social 
    Family Support 
    Social Support 
 
 
33.4 (0.1)*** 
23.6 (0.1)*** 
 
32.6 (0.3) 
22.3 (0.2) 
 
32.9 (0.2)*** 
23.4 (0.2)*** 
 
31.3 (0.5) 
22.1 (0.4) 
 Personality 
    Adolescent Neuroticism 
    Adolescent Conscientiousness 
    Adult Neuroticism 
    Adult Conscientiousness 
 
9.7 (0.1)*** 
15.1 (0.1) 
10.7 (0.1)*** 
15.0 (0.1)*** 
 
 
10.4 (0.2)*** 
15.2 (0.1) 
11.7 (0.2) 
13.9 (0.2) 
 
 
10.2 (0.1)*** 
15.0 (0.1) 
11.3 (0.1)*** 
14.9 (0.1)*** 
 
 
11.1 (0.3) 
14.9 (0.2) 
12.0 (0.3) 
13.6 (0.3) 
 
 Cognitive 
    Cognitive Control 
    Memory 
 
20.4 (0.1)*** 
4.1 (0.0) 
 
17.5 (0.2)*** 
3.9 (0.1) 
 
19.5 (0.2)*** 
4.2 (0.1) 
 
16.8 (0.4) 
4.0 (0.1) 
 
Psychiatric [weighted % (SE)] 
    
    Major Depression 
    Anxiety Disorder 
    Alcohol Use Disorder 
    Substance Use Disorder 
    Childhood Abuse 
18.3 (0.9)*** 
14.3* (0.8)** 
20.1 (1.0)* 
5.2 (0.5)*** 
34.7 (1.2)*** 
32.9 (2.8)*** 
25.0 (2.3)** 
26.3 (2.2) 
9.4 (1.3)** 
44.4 (2.8)*** 
26.5 (2.1)*** 
23.2 (1.7)*** 
28.2 (2.2) 
8.4 (1.2)** 
38.6 (2.1)*** 
49.5 (3.4) 
37.0 (4.0) 
28.8 (3.4) 
17.1 (2.9) 
62.7 (3.6) 
Notes: Compared to Comorbid ADHD/ED: *p<.05; **p<.01; ***p<.001 
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Table 13 displays these differences by disorder status among males. There were no 
differences by disorder status with regards to social factors, personality in adolescence, and 
memory. A few personality differences at wave IV were found; males with comorbid ADHD/ED 
had higher adult neuroticism scores than males with neither disorder, and lower adult 
conscientiousness scores than males with neither disorder and males with ED alone. Males with 
the comorbidity had lower cognitive control scores compared to all other groups. Lastly, there 
were several differences within the psychiatric factors. Males with the comorbidity had higher 
rates of depression compared to males with neither disorder and males with ED alone, and 
higher rates of anxiety disorder compared to all groups. Males with the comorbidity also had 
higher rates of childhood abuse as compared to males with neither disorder. 
 
Table 13. Psychosocial and Psychiatric Risk Regulator Descriptives by Disorder Status 
among Males (n=5,248) 
 Neither 
Disorder 
(n=4,335) 
ADHD 
Alone 
(n=656) 
ED 
Alone 
(n=1,033) 
Comorbid 
ADHD/ED 
(n=265) 
Psychosocial [weighted mean (SE)]     
 Social 
    Family Support 
    Social Support 
 
34.4 (0.1) 
23.7 (0.1) 
 
33.6 (0.2) 
22.5 (0.2) 
 
34.1 (0.3) 
23.7 (0.2) 
 
34.2 (0.4) 
23.3 (0.5) 
 
 Personality 
    Adolescent Neuroticism 
    Adolescent Conscientiousness 
    Adult Neuroticism 
    Adult Conscientiousness 
 
 
8.7 (0.1) 
15.2 (0.1) 
9.7 (0.1)* 
14.6 (0.1)* 
 
 
9.3 (0.1) 
14.9 (0.1) 
10.2 (0.1) 
13.6 (0.1) 
 
 
9.1 (0.2) 
15.3 (0.2) 
10.0 (0.2) 
14.2 (0.2)* 
 
 
9.0 (0.3) 
15.1 (0.3) 
10.8 (0.3) 
13.5 (0.4) 
 
 Cognitive 
    Cognitive Control 
    Memory 
 
 
19.2 (0.1)*** 
4.2 (0.1) 
 
 
17.2 (0.1)*** 
4.2 (0.1) 
 
 
18.7 (0.3)*** 
4.1 (0.1) 
 
 
15.7 (0.5) 
3.9 (0.2) 
 
Psychiatric [weighted % (SE)] 
    
    Major Depression 
    Anxiety Disorder 
    Alcohol Use Disorder 
    Substance Use Disorder 
    Childhood Abuse 
7.8 (0.6)*** 
7.0 (0.7)*** 
30.8 (1.3) 
7.8 (0.6) 
34.9 (1.3)* 
15.6 (1.7) 
9.7 (1.1)* 
36.1 (2.2) 
13.7 (1.3) 
42.7 (1.8) 
9.6 (2.0)** 
7.6 (1.8)** 
34.4 (3.0) 
9.1 (2.1) 
39.9 (3.9) 
21.1 (4.1) 
16.1 (3.5) 
32.8 (4.9) 
13.3 (3.3) 
45.4 (5.0) 
Notes: Compared to Comorbid ADHD/ED: *p<.05; **p<.01; ***p<.001 
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Aim One Results 
 Aim one is to evaluate a model of the underlying mechanisms of the ADHD/ED 
comorbidity. Individual, unadjusted logistic regressions were constructed for each hypothesized 
underlying mechanism among females. Figure 5 displays the results of the association between 
each mechanism with ADHD alone and ED alone. As can be seen in figure 5, none of the 
genetic factors were associated either ADHD or ED alone. However, several psychosocial 
factors were correlated with each disorder. Specifically with regards to ADHD alone, significant 
correlations included decreased family support (OR: 0.97, 95% CI: 0.96-0.99), social support 
(OR: 0.93, 95% CI: 0.91-0.96), adult conscientiousness (OR: 0.87, 95% CI: 0.84-0.91), cognitive 
control (OR: 0.85, 95% CI: 0.82-0.87), and memory (OR: 0.92, 95% CI: 0.86-0.99), and 
increased adolescent (OR: 1.05, 95% CI: 1.02-1.08), and adult neuroticism (OR: 1.11, 95% CI: 
1.07-1.16). There were less correlates to ED alone. Significant associations included decreased 
family support (OR: 0.98, 95% CI: 0.97-0.99), and increased adolescent (OR: 1.03, 95% CI: 
1.01-1.06), and adult neuroticism (OR: 1.06, 95% CI: 1.03-1.10). 
Generally speaking, all psychiatric factors were significantly associated with both ADHD 
alone and ED alone with the exception of no association between substance use disorder and 
childhood abuse with ED alone. For ADHD alone, positive significant associations were as 
follows: major depression (OR: 1.80, 95% CI: 1.38-2.36), anxiety disorder (OR: 1.61, 95% CI: 
1.25-2.08), alcohol use disorder (OR: 1.26, 95% CI: 1.01-1.58), substance use disorder (OR: 
1.54, 95% CI: 1.08-2.18), and childhood abuse (OR: 1.37, 95% CI: 1.10-1.72). Positive 
significant associations with regards to ED alone were as follows: major depression (OR: 1.29, 
95% CI: 1.04-1.59), anxiety disorder (OR: 1.49, 95% CI: 1.22-1.81), and alcohol use disorder 
(OR: 1.45, 95% CI: 1.16-1.81). 
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Figure 5: Individual Logistic Regressions of the Association of Each Hypothesized 
Underlying Factor with ADHD Alone and ED Alone Among Females (n=6,289) 
 
Figure 6 displays the results of similar logistic regression models of each underlying 
mechanism as associated with comorbid ADHD/ED. Within the genetic substrate, any short 5-
HTTLPR repeats were positively associated (OR: 1.45, 95% CI: 1.01-2.06). Among 
psychosocial factors, positive associations included adolescent (OR: 1.12, 95% CI: 1.07-1.17), 
and adult neuroticism (OR: 1.15, 95% CI: 1.07-1.22). Negative associations included family 
support (OR: 0.93, 95% CI: 0.91-0.96), social support (OR: 0.93, 95% CI: 0.89-0.96), 
adolescent conscientiousness (OR: 0.85, 95% CI: 0.80-0.91), and cognitive control (OR: 0.82, 
95% CI: 0.79-0.86). 
Psychiatric factors, with the exception of alcohol use disorder, were all positively 
associated with comorbid ADHD/ED. Generally speaking, females with each of the psychiatric 
factors were between approximately three to four times more likely to have comorbid ADHD/ED: 
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major depression (OR: 3.58, 95% CI: 2.74-4.69), anxiety disorder (OR: 2.85, 95% CI: 2.01-
4.03), substance use disorder (OR: 3.09, 95% CI: 2.02-4.71), and childhood abuse (OR: 2.93, 
95% CI: 2.14-4.00). 
 
Figure 6: Individual Logistic Regressions of the Association of Each Hypothesized 
Underlying Factor Comorbid ADHD/ ED Among Females (n=6,289) 
 
 Based on the results of the logistic regression models displayed in figure 6, the following 
factors were retained for structural equation modeling: childhood abuse, substance use 
disorder, anxiety disorder, major depression, cognitive control, conscientiousness at wave IV, 
neuroticism at both wave I and wave IV, social support, family support, and all genetic factors.  
In order to investigate mediating factors, the model included any ADHD and any ED indicators 
as opposed to the ADHD alone and ED alone indicators. 
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The initial model, based on the conceptual framework (figure 2), resulted in poor model 
fit as none of the genetic factors were leading to either disorder or the comorbidity. Based on 
this finding, the model was re-constructed as a mediation model focusing on H2 (psychosocial 
factors) and H3 (psychiatric factors), with the genetic factors predicted to be associated with 
each of the H2 and H3 factors per pathway three of the conceptual framework. This re-
construction dropped the comorbidity indicator from the model; as each H2 and H3 factor was 
predicted to mediate the relationship of the two disorders as opposed to directly lead to 
comorbidity. 
 
 
Figure 7. Structural Equation Model of the Underlying Mechanisms of Comorbid  
ADHD/ EDs among Females (n=6,289) 
 
Although fit improved, the re-constructed model still had inadequate fit, and several 
factors including the DAT1 ten repeat, DRD4 seven repeat, social support, conscientiousness, 
and childhood abuse were not significant within the model. Guided by analysis of standardized 
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residuals, modification indices, as well as theoretical considerations, several rounds of re-
specification resulted in the final model shown in figure 7. Figure 7 displays standardized 
estimates with all one directional associations connected with solid lines and all bidirectional 
relationships (i.e., correlations) connected with dotted lines. 
This final model has great fit with the following indices: Χ2 (df=17)=37.93, p=.0025; 
RMSEA=.01; CFI=.95; WRMR=.89. Psychosocial and psychiatric factors retained as significant 
in this final model included depression, anxiety, substance use disorder, cognitive control, and 
family support. Results suggest that while ADHD is directly associated with ED (standardized 
estimate: 0.05, p<.05), there are also several indirect pathways from ADHD to ED. 
Both psychosocial factors partially mediated the relationship between the two disorders 
in that ADHD was negatively associated with both cognitive control and family support, which 
each subsequently were negatively associated with ED. H3 proposed that psychiatric factors 
mediate the relationship just as the psychosocial factors; however, this was not consistent with 
model findings. ADHD was positively associated with each psychiatric factor (major depression, 
anxiety disorder, and substance use disorder). However, these factors did not lead to EDs in 
one directional nature as predicted, rather bidirectional correlations were found. This suggests 
that rather than mediating ADHD to ED, it appears that the other psychiatric illnesses, including 
depression, anxiety, and substance use, were each correlated or comorbid with EDs on their 
own. ADHD lead to both ED and the second comorbid illness in single directional relationships. 
Several genetic factors predicted psychosocial and psychiatric factors, as proposed in 
pathway three. Specifically, any active MAOA was associated with major depression, any DAT1 
nine repeats was associated with anxiety disorder, and any short 5-HTTLPR repeats was linked 
to cognitive control. Lastly, as predicted, all psychosocial and psychiatric factors were 
significantly correlated. The accumulation of all pathways from ADHD to ED equated to a total 
standardized effect of 0.09 (p<.001). 
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Aim Two Results 
 Aim two explored the comorbidity and underlying mechanisms among males.  Table 14 
displays descriptives and comparative associations of demographic, physical health, behavioral 
health factors by disorder status for men. There were few differences between each sub-group 
with regards to demographic factors. The only significant differences were related to education 
and perceived intelligence. Males with comorbid ADHD/ED had significantly lower high school 
graduation rates by wave III (39.2%), as compared to men with neither disorder (51.1%, p<.05), 
and males with ED alone (58.1%, p<.01). Similarly, a significantly lower proportion of males with 
the comorbidity perceived themselves to be of above average intelligence (52.7%) as compared 
to men with neither disorder (63.9%, p<.05), and males with ED alone (67.8%, p<.05). 
 There was no physical health differences observed between men with the comorbidity 
and men with ED alone. Compared to men with neither disorder, men with comorbid ADHD/ED 
had higher levels of physical activity at wave III (8.6 v. 6.8, p<.01), higher rates of performance 
enhancer or steroid use (24.1% v. 15.9%, p<.05), higher rates of hypertension (41.0% v. 31.4%, 
p<.01), higher average body mass index scores at both wave I (23.7 v. 22.6, p<.001), and wave 
III (28.4 v. 26.2, p<.001), and higher rates of obesity at wave III (34.3% v. 19.8%, p<.01). 
Similarly results were obtained when compared to the ADHD alone group in that men with the 
comorbidity had higher rates of performance enhancer or steroid use (24.1% v. 14.9%, p<.01), 
higher average body mass index scores at both wave I (23.7 vs. 22.5, p<.001), and wave III 
(28.4 v. 26.1, p<.001), and higher rates of obesity at wave III (34.3% v. 22.5%, p<.01). 
There was no behavioral health differences observed between men with the comorbidity 
and men with ADHD alone. However, as compared to men with neither disorder, a higher 
proportion of men with comorbid ADHD/ED reported being in psychological counseling within 
the year prior to wave III (10.7% vs. 3.9%, p<.05). Men with the comorbidity also had higher 
delinquency scores (5.3 vs. 4.5, p<.01), higher rates of having ever been arrested (50.3% vs. 
38.7%, p<.05), and higher average number of lifetime sex partners (24.4 vs. 15.9, p<.05) as 
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compared to men with neither disorder. Lastly, as compared to men with ED alone, males with 
comorbid ADHD/ED had higher rates of having ever been arrested (50.3% vs. 34.1%, p<.01), 
and lower average age of sexual initiation (15.4 vs. 16.4, p<.05). 
There were several differences that did not hit a statistically significant level, but are still 
worth noting, as the lack of significance may be due to power related concerns. Men with ADHD 
alone were physically active 6.9 times in the past week at wave III as compared to the 8.6 times 
men with ED alone, and 8.6 times men with the comorbidity were active. Rates of high 
cholesterol and hypertension were both higher among men with comorbid ADHD/ED than the 
other three categories. Although not significant, the rate of obesity at wave I was almost double 
among men with the comorbidity (13%) compared to men with ADHD alone (6.9%), and men 
with neither disorder (7.7%). While body mass index and obesity seemed to be higher when 
compared to the other groups, there was no difference in regards to either indicator between 
men with the comorbidity and men with ED alone. 
With regards to noteworthy non-significant findings among the behavioral health factors, 
a lower proportion of men with ED alone were in psychological counseling (4.5%), compared to 
men with the comorbidity (10.7%). The average number of lifetime sexual partners was 
significantly higher among males with the comorbidity as compared to males with neither 
disorder. Although not significantly, the average was also highest among males with the 
comorbidity (24.4), compared to men with ADHD alone (19.6) and ED alone (14.5). Lastly, there 
appears to be small differences in the proportion of men that identify as homosexual. The lowest 
rates were among males with neither disorder (1.6%), and ADHD alone (1.5%). It was 
somewhat higher among males with the comorbidity (3.3%) and highest among males with ED 
alone (4.8%). 
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Table 14. Associated Demographic, Physical Health, and Behavioral Health 
Characteristics of Males by Disorder Status	  	   Neither 
Disorder 
(n=3,522)	   ADHD Alone (n=1,124)	   ED  Alone (n=417)	   Comorbid ADHD/ED (n=185)	  
Demographic Profile	   	   	   	   	  
Race and Nationality 
    White (Non-Hispanic) 
    Black (Non-Hispanic) 
    Hispanic 
    Asian 
    Another Race	  
 
63.5 (3.2) 
16.5 (2.3) 
12.7 (1.9) 
3.8 (0.9) 
3.5 (0.5)	  
 
72.5 (3.0) 
13.3 (2.3) 
8.4 (1.5) 
3.1 (1.0) 
2.8 (0.7)	  
 
60.5 (4.8) 
15.1 (2.9) 
15.4 (4.0) 
5.7 (1.8) 
3.3 (1.3)	  
 
65.2 (5.4) 
12.8 (4.3) 
13.8 (3.5) 
3.1 (2.1) 
5.1 (2.1)	  
Education 
    High School Graduate by Wave III 
    Self Perceived Above Average Intelligence	    51.1 (2.4)* 63.9 (1.3)*	    41.1 (2.6) 59.5 (2.2)	    58.1 (3.6)** 67.8 (3.7)*	    39.2 (5.8) 52.7 (6.0)	  
Parent Education Level 
    High School Graduate	    83.3 (1.7)	    85.5 (2.2)	    86.0 (2.9)	    83.6 (4.8)	  
Annual Family Income at Wave I 
    Less than $24,000 
    $24,000 – $44,999 
    $45,000 or Higher 
    Unknown3	  
 
23.3 (1.8) 
25.8 (1.2) 
30.8 (2.0) 
20.1 (1.1)	  
 
25.3 (2.6) 
24.5 (1.8) 
30.1 (2.2) 
20.0 (2.0)	  
 
18.1 (3.2) 
23.1 (3.3) 
37.3 (3.6) 
21.5 (3.2)	  
 
23.3 (5.6) 
20.8 (3.9) 
37.6 (5.1) 
18.3 (3.5)	  
 
Physical Health Profile	   	   	   	   	  
Physical Activity 
    Past Week Physical Activity at Wave I1 
    Past Week Physical Activity at Wave III1 
    Performance Enhancer or Steroid Use	  
 
4.1 (0.1) 
6.8 (0.2)** 
15.9 (1.0)*	  
 
4.2 (0.1) 
6.9 (0.3) 
14.9 (1.4)**	  
 
4.3 (0.2) 
8.2 (0.5) 
23.1 (3.5)	  
 
4.2 (0.2) 
8.6 (7.2) 
24.1 (3.9)	  
Health Conditions 
    High Cholesterol by Wave IV 
    Hypertension by Wave IV	    7.6 (0.6) 31.4 (1.1)*	    8.9 (1.2) 35.3 (1.8)	    9.7 (2.1) 34.7 (3.3)	    11.0 (2.7) 41.0 (5.1)	  
Weight Related Conditions 
    (Self-Report) BMI at Wave I1 
    (Self-Report) Obesity at Wave I 
    (Measured) BMI at Wave III1 
    (Measured) Obesity at Wave III	  
 
22.6 (0.1)*** 
7.7 (0.7) 
26.2 (0.1)*** 
19.8 (1.1)**	  
 
22.5 (0.2)*** 
6.9 (1.1) 
26.1 (0.2)*** 
22.5 (1.9)*	  
 
24.2 (0.3) 
14.8 (2.9) 
28.1 (0.4) 
31.1 (3.1)	  
 
23.7 (0.5) 
13.0 (5.1) 
28.4 (0.8) 
34.3 (5.3)	  
 
Behavioral Health Profile	   	   	   	   	  
Mental Health Care Utilization 
    Psychological Counseling at Wave III 
    Drug or Alcohol Abuse Treatment at Wave III	    3.9 (0.5)* 3.5 (0.4)	    10.2 (1.3) 5.5 (0.8)	    4.5 (1.6) 2.8 (1.2)	    10.7 (3.5) 4.8 (1.9)	  
Delinquent Behavior 
    Delinquency Scale at Wave I1 
    Ever Arrested by Wave IV	    4.5 (0.2)** 38.7 (1.4)*	    5.6 (0.3) 49.6 (2.2)	    4.9 (0.4) 34.1 (2.9)**	    5.3 (0.6) 50.3 (4.8)	  
Sexual Behaviors 
    Age at First Sex1 
    Number of Lifetime Sex Partners at Wave IV1 
Sexual Orientation 
    100% or Mostly Homosexual	  
 
16.0 (0.1) 
15.9 (0.8)* 
 
1.6 (0.3)	  
 
15.3 (0.2) 
19.6 (1.4) 
 
1.5 (0.5)	  
 
16.4 (0.3)* 
14.5 (1.3) 
 
4.8 (1.6)	  
 
15.4 (0.4) 
24.4 (4.3) 
 
3.3 (1.6)	  
Notes: Weighted % (SE)  
1Weighted Mean (SE) 
* p<.05, ** p<.01, ***p<.001	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As had been done in aim one, individual, unadjusted logistic regressions were 
constructed for each hypothesized underlying mechanism among males in order to investigate 
the association of each with comorbid ADHD/ED (see figure 8). Descriptive statistics and 
comparison tests described above resulted in very few significant differences between males 
with comorbid ADHD/ED and males in the other subgroups. Accordingly, there were few 
significantly associations of proposed underlying mechanisms with comorbid ADHD/ED among 
males. 
 
 
Figure 8. Individual Logistic Regressions of the Association of Each Hypothesized 
Underlying Factor with Comorbid ADHD/ ED Among Males (n=5,248) 
 
Results of logistic models (see figure 8) found that men with higher adult 
conscientiousness and cognitive control scores were less likely to have comorbid ADHD/ED 
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(conscientiousness: OR: 0.90, 95% CI: 0.82-0.99; cognitive control: OR: 0.83, 95% CI: 0.78-
0.88). Conversely, males with higher adult neuroticism scores were more likely to have 
comorbid ADHD/ED (OR: 1.13, 95% CI: 1.04-1.23). Most noteworthy, men with major 
depression and men with anxiety disorders were both more than twice as likely to have 
comorbid ADHD/ED (depression: OR: 2.46, 95% CI: 1.49-4.06; anxiety: OR: 2.29, 95% CI: 1.35-
3.88).   
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CHAPTER FIVE: DISCUSSION 
 
  Findings of this study provide support for several hypothesized underlying mechanisms 
of the ADHD/ED comorbidity. Specifically, among females, factors including cognitive control, 
family support, and additional comorbid mental health illnesses such as depression, anxiety, 
and substance disorder all mediate the relationship between ADHD and EDs. However, rather 
than leading to the comorbidity, ADHD led to other mental health issues which were then 
subsequently correlated to EDs; suggesting a comorbidity between these additional disorders 
and EDs with ADHD being a possible predictor of that comorbidity. This finding requires 
additional research with primary data collection to be confirmed. Moreover, other potential co-
occurring mental disorders, such as bipolar disorder and OCD still require examination. 
  While a model of the underlying mechanisms is described in this study, this may be one 
of many potential models. Several factors that were significantly associated with ADHD alone, 
EDs alone, and the comorbidity via unadjusted analyses were dropped from the final model. 
These factors may still be underlying mechanisms, however they may be part of a separate 
combination of factors. Additional exploration is needed in regards to other potential 
combinations of underlying mechanisms.  
  In regards to genetics, the factors investigated in this study were not found to be directly 
associated with the comorbidity. Rather, these factors were connected to the psychosocial and 
psychiatric mediators, suggesting an indirect relationship between genetics and the comorbidity. 
Most importantly, while the model attenuated the relationship between ADHD and EDs, there 
was still a slightly significant pathway directly from ADHD to EDs. This suggests that the factors 
included in the model are still not completely explaining the connection between the two 
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disorders. Additional unexplored factors may help to fully account for the connection between 
ADHD and EDs.  
With regards to males, comparisons of men with ADHD alone, EDs alone, and neither 
disorder suggest that there may be some noticeable differences compared to men with the 
comorbidity. Differences in regards to education attainment, BMI and obesity, delinquent 
behavior, and sexual behaviors were all observed. However, these differences alone may not 
be enough to identify the subset of males with ADHD or EDs that are at risk for the comorbidity. 
Replications of these results are needed with primary data collection to confirm, as well as to 
identify other potential differences. Moreover, very few of the proposed underlying mechanisms 
among females were significantly associated with the comorbidity among males. Continued 
research related to the development of the comorbidity in this population is needed to better 
understand potential male-specific determinants of comorbid ADHD/ EDs. 
 
Genetic Conclusions 
There are several potential explanations for the lack of significant findings related to the 
genetic substrate. One is that this study explored the specific repeat patterns in isolation from 
accompanying genotypes. For example, both any nine repeats and any ten repeats of the DAT1 
gene were investigated; however, these repeats were explored independently by comparing any 
nines and any tens on either allele separately to all other repeat options as opposed to each 
other. Yet it may not be the singular repeat patterns of nines or tens that lead to the comorbidity 
but combinations including these repeats. For example studies have compared the nine/nine 
genotype with the ten/ten and also ten/nine genotype (Guo et al., 2010). The unexplored 
ten/nine combination may play a role. 
Additionally, this study compared any of the specified repeat patterns as opposed to 
comparing specific two chromosome genotypes. For example, the key genetic component may 
not be any nines but specifically one nine repeat or two nines (nine/nine). With two 
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chromosomes and two repeat sequences for each gene candidate, the combination repeats 
may have a role. For example, one study found differences in high calorie food intake between 
females with a ten/ten genotype on the SLC6A3 gene as compared to any nine repeats (Agurs-
Collins & Fuemmeler, 2011). 
Similarly, the identified repeat patterns of interest might not be the true component 
leading to the comorbidity. For example the two/two repeat of the DRD4 gene has been 
associated with increased depression levels (Guo & Tillman, 2009), and repeats greater than 
seven, as opposed to exactly seven has been linked to comorbid depression and marijuana use 
(Bobadilla et al., 2013). These and other repeats could potentially lead to comorbid ADHD/ EDs. 
Specific genotypes of both alleles and additional repeat patterns warrant additional research. 
Beyond additional genotype patterns and repeats sequences, it may be different genes 
that explain the comorbidity. There are several possible genes not included in this study that 
may be among the underlying mechanisms of comorbid ADHD/ED. These include DRD2, which 
has been linked to substance abuse, eating pathology, obesity, and ADHD (Agurs-Collins & 
Fuemmeler, 2011; Comings et al., 2000; Pagoto et al., 2009), in addition to DRD1, DRD3, and 
DRD5 (Comings et al., 2000; Davis et al., 2009). One study related to the RDS reported that 
noradrenergic genes such as DBH Taq I, ADRA2A, and ADRA2C were more important in 
ADHD than dopamine or serotonin genes (Comings & Blum, 2000; Comings et al., 2000). 
Alterations in the catecholamine-O-methyltransferase (COMT) enzyme, which affects memory 
and attention, have also been suggested as the common underlying biological mechanism of 
both disorders (Kapoor, 2008). High levels of COMT activity have been observed in ADHD 
patients (Eisenberg et al., 1999), and it increases the risk of developing binge eating (Frieling et 
al., 2006; Mikołajczyk, Śmiarowska, Grzywacz, & Samochowiec, 2006). As literature on the 
genetic influences of mental illness continue to expand in accordance with the new RDoC 
matrix, these additional genetic factors should be evaluated in conjunction with the additional 
repeat sequences, genotype patterns, as well as the genetic factors included within this study. 
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It is also important to note that the initial hypothesis of the RDS was that defects in 
dopamine, a neurotransmitter, leads to reward seeking behavior associated with ADHD and 
EDs. Genetic factors are important because they influence the development and regulation of 
dopamine. However, genes may be indirect to the true underlying mechanism of the 
neurobiology of the person.  
With a limited number of options, the cited repeat sequences in this study are very 
common in the general populations. For example with the DRD4 gene, the two, three, four, and 
seven repeats account for 98% of the population (Lichter et al., 1993), yet not everyone 
develops ADHD, EDs, or other associated dopamine related mental illnesses. The existence of 
the repeat pattern might not be as important as the factors causing the gene to manifest as RDS 
and mental illness.  
Similarly, many of the genes described in this study are associated with several other 
mental health and risk taking outcomes. MAOA is linked to alcoholism and drug abuse 
(Comings et al., 2000). The DAT1 gene has been linked to delinquency, increased number of 
sexual partners, binge drinking, smoking quantity and frequency, marijuana use, cocaine and 
other illegal drug use, and lack of seatbelt use (Guo et al., 2010). The serotonin transporter 
gene has been linked to marijuana use, neglect, criminal activity, antisocial behaviors, and 
overall life satisfaction (De Neve, 2011; Vaske, Newsome, & Wright, 2012). The factors that 
cause dopamine based genetic components to manifest as the RDS and ADHD and EDs as 
opposed to these other illnesses is not fully understood. Improved understanding in these 
factors might better explain the biological underlying mechanism and could guide neuroscience 
based screening tools. 
Lastly, It has been suggested that investigations of genetic and environmental 
interactions that typically focus on one factor at a time may result in constrained views of the 
social world (Shanahan, Vaisey, Erickson, & Smolen, 2008). The independent analysis of each 
gene within the current study may be subject to this concern. Along with the constrained view, 
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the reward deficiency syndrome is polygenic, meaning that many genes and neurotransmitters 
play a role (Comings et al., 2000). It may not be any gene independently but the combination or 
interactions of many genes that result in comorbid ADHD/ EDs. 
 
Next Steps 
As mentioned above, it has been said that investigating genetic and environmental 
interactions one factor at a time leads to constrained conclusions (Shanahan et al., 2008). This 
limitation was recognized within a study that aimed to explore the interactions of social capital, 
DRD2, and educational attainment. In order to overcome the limitation, the study utilized 
qualitative comparative analysis to determine the multiple combinations of factors leading to 
their predicted outcome (Shanahan et al., 2008). Based on the conclusion that the model 
described in this study may be just one of several potential combinations of underlying 
mechanisms, continued research in this area could benefit from further exploration using similar 
qualitative comparative analysis techniques. This form of analysis would help establish all 
possible groupings of factors that lead to comorbid ADHD/ ED, which would help continue to 
improve the overall understanding of the mechanisms that foster the comorbidity in different 
people. 
Although both genetics and the psychosocial and psychiatric factors were included 
within the model simultaneously, this study did not investigate the many possible direct 
interactions. Key interacting combinations might have been missed. For example, an interaction 
between the serotonin transporter gene with stress predicts ADHD severity (Meer et al., 2014). 
Similarly, gene x environment interactions of the serotonin transporter with home and 
neighborhood quality predicts self-esteem (Jonassaint et al., 2012). Future investigations should 
focus on improving our understanding of all mechanisms to the comorbidity as well as their 
interacting effects. Lastly, due to the limitations of this secondary data analysis and potential 
measurement concerns, next steps will include comparisons to other large national datasets 
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and ultimately primary data collected. This will both allow for the addition of several other 
potential underlying mechanisms and will be used to verify this study’s findings. 
   
Implications 
 Once the full picture of the underlying mechanisms of ADHD and EDs is understood, next 
steps include the development of prevention programs and improved treatment plans. This 
comorbidity has implications in many areas including primary and secondary prevention of EDs, 
improved treatment plans, prevention of psychostimulant medication abuse, and prevention and 
treatment of obesity. 
 
Implications for ED Prevention 
 Historically, successful eating disorder prevention programs have been, female-focused, 
selective as opposed to universal, and targeted to older teens (over fifteen years old) (Stice, 
Shaw, & Marti, 2007). There has been a noted need for prevention at a universal level that 
address a broad spectrum of weight-related problems (Ciao et al., 2014). ADHD is most 
commonly associated with binge eating (Cortese et al., 2007), both of which are then associated 
with obesity (Cortese et al., 2008). Capitalizing on the comorbidity between ADHD and EDs via 
targeting children with ADHD for ED prevention efforts may address some of the gaps in the 
current prevention literature through the prevention of several weight-related problems including 
binge eating and obesity. 
 Additionally, secondary prevention is considered a promising area for early intervention 
of EDs (Ciao et al., 2014). Early detection, or secondary prevention is crucial in that it can 
increase the likelihood of long-term recovery as delays in treatment are associated with 
prolonged illness, poor prognosis, and relapse (Agras, 2001; Cavanaugh & Lemberg, 1999; 
Mitchell, 1995; National Eating Disorder Association, n.d.; Thompson & Smolak, 2001; 
Thompson & Smolak, 2001). However, less than a third of cases are detected by healthcare 
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professionals (Keski-Rahkonen et al., 2009). Potential influencing factors of the low rates of 
early detection may be the lack of effective training and integrated care. The majority of 
physicians report being dissatisfied with the quality of ED educations in training programs. 
These deficiencies in education are particularly prominent in the children’s health systems in 
regards to assessment and treatment among adolescents (Girz et al., 2014), resulting in as 
many as 90% of family physicians reporting low levels of self-competence with regard to 
assessment and treatment of EDs in children and adolescents (Girz et al., 2014; Robinson et 
al., 2013).  
The ADHD/ ED comorbidity has the potential to impact care integration. Mental health 
professionals typically treat EDs (Hay, 2013; Smolak & Thompson, 2009; Stein et al., 2009), 
while ADHD is primarily assessed and treated by primary care physicians (Rader et al., 2009). 
The lack of integrated care for children with ADHD may contribute to both the low levels of 
competence among primary care providers and the low rates of early detection. This allows for 
an opportunity to develop secondary prevention efforts via physicians treating adolescents with 
ADHD as well as the promotion of care integration through a medical health team (e.g., health 
homes, accountable care organizations). 
The development of a comprehensive model of the underlying mechanisms associated 
with comorbid ADHD and EDs can help target the specific subset of patients that would most 
benefit from these prevention efforts as well as additional primary prevention. The 
understanding of the underlying factors could help develop screening tools to identify the at-risk 
subset of ADHD patients who then could be targeted for ED prevention.   
Concomitantly, improved education of EDs and ED related consequences could be 
developed and delivered to both parents and adolescents with ADHD. Additional behavioral 
monitoring plans could be developed and enacted. In additional based on the impulse related 
eating as well as consequences of ADHD medications on night time eating, (described below), 
may result in the need for ADHD specific nutrition plans. Dieticians could work with families of 
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children with ADHD to establish plans specifically to help reduce the potential for binge eating. 
The improvement of primary and secondary prevention of EDs among children and adolescents 
with ADHD via identification, referral, education, and monitoring could help address the Healthy 
People 2020 objective of reducing the prevalence of disorder eating behaviors in adolescents 
(U.S. Department of Health and Human Services, 2012). 
 
Implications for Males with EDs 
 Implications for ED prevention via children and adolescents with ADHD could also 
extend to males. It is generally accepted that male EDs are underdiagnosed and misunderstood 
(Smink et al., 2012; Strother et al., 2012). While binge eating is the most common ED amongst 
males, to date the literature has focused on exercise behavior (Núñez-Navarro et al., 2012; 
Stoving et al., 2011; Strother et al., 2012) and restriction among homosexual males (Fernández-
Aranda et al., 2004; Shiltz). Despites this lack of information, previous studies have found a 
significant gender differences in terms of manifestation and symptomology (Núñez-Navarro et 
al., 2012), risk factors (Strother et al., 2012), and outcomes of EDs (Stoving et al., 2011). 
Additionally, females are more likely to receive treatment for an ED and also to receive 
treatment longer than males (Stuhldreher et al., 2012). While outcomes appear to be better 
among males in terms of time to remission (Stoving et al., 2011), the majority of effective ED 
prevention efforts and research have been female focused (Ciao et al., 2014). 
Information about the male specific determinants and correlates of comorbid ADHD/ EDs 
could help in the development of ED prevention efforts among this at-risk population that 
currently lack prevention efforts.  Moreover, ADHD and binge eating are strongly associated 
with obesity (Cortese et al., 2008; Cortese et al., 2007; Davis et al., 2006; Nazar et al., 2008), 
and males with EDs more often have a history of obesity compared to females with EDs 
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(Fernández-Aranda et al., 2004; Núñez-Navarro et al., 2012). Thus, the development of ED 
prevention among males with ADHD may also address the call for prevention of broad spectrum 
weight-related problems prevention (Ciao et al., 2014). 
   
Implications for Integrated Treatment Plans 
The first-line treatment for ADHD is psychostimulant medication (Farber, 2010; 
Krisanaprakornkit, Ngamjarus, Witoonchart, & Piyavhatkul, 2010; National Institutes of Mental 
Health, 2008; Rader et al., 2009). The rate of medication use is on the rise. In 2011, 69% of 
children with an ADHD diagnosis were using medication (Visser et al., 2014). In terms of the 
general population, in 2011, 6.1% of all children in the United States, or 3.5 million, were using 
prescribed ADHD medication, up from 4.8% in 2007 (Visser et al., 2014). While stimulants are 
often very effective in reducing the impairment of ADHD, common side effects of these 
medications include appetite suppression and weight loss (Farber, 2010; Krisanaprakornkit et 
al., 2010; National Institutes of Mental Health, 2008; Rader et al., 2009). Some of the issues 
resulting from psychostimulants might include nighttime binge eating resulting from appetite 
suppression and decreased daytime food intake followed by increased eating at night when the 
medications wear off (Racicka, Hanć, Giertuga, Bryńska, & Wolańczyk, 2015). 
  While psychostimulant medications are common, there are non-stimulant options for 
children with ADHD including norepinephrine-reuptake inhibitors and antidepressants (Rader et 
al., 2009). Several antidepressants target dopamine receptors (Rader et al., 2009). The 
potential dopamine imbalance underlying mechanism of the ADHD/ED comorbidity might 
suggest that these medications could be a better option for the subset of patients with both 
disorders. Clinical trials for these treatment options have shown effectiveness; however, these 
non-stimulant options are typically reserved as a second line option for children that do not 
respond to psychostimulants (Rader et al., 2009). The use of dopamine targeting 
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antidepressants would treat the underlying biological factors as opposed to the behavioral 
manifestations of the RDS. It would also eliminate potential harmful ED related side effects from 
the stimulants. 
  The reduced cognitive control underlying mechanism can also inform improved 
treatment plans. Rather than giving patients with comorbid ADHD/ ED a cognitive enhancing 
medication, patients that are identified as at-risk might benefit from behavioral focused options 
such as cognitive behavioral therapy. Cognitive behavioral therapy is an effective treatment 
option for both ADHD and BED (Iacovino, Gredysa, Altman, & Wilfley, 2012; National Institute of 
Mental Health, 2008; Wilson, Wilfley, Agras, & Bryson, 2010). Additionally, several studies have 
noted positive outcomes from guided self-help based cognitive behavior therapy on reducing 
binge eating episodes (Lynch et al., 2010; Striegel-Moore et al., 2010; Wilson et al., 2010). 
ADHD/ED specific treatment options like cognitive behavioral therapy would allow for 
collaborative treatment plans in which a single method is used to address both disorders. 
 Although there are concerns related to the use of psychostimulants among patients with 
EDs (Farber, 2010; Keshen & Ivanova, 2013), there is also evidence that psychostimulants may 
be effective in treating BN and BED by reducing binge eating episodes (Dukarm, 2005; Kooij et 
al., 2004; Sokol, Gray, Goldstein, & Kaye, 1999). On January 30, 2015 the food and drug 
administration approved the use of Vyvanse, a psychostimulant developed for the treatment of 
ADHD, for treating BED among adults (U.S. Food and Drug Administration, 2015). This is the 
first approved medication for BED. 
While there have been several published case studies demonstrating positive impacts of 
psychostimulants on binging (Keshen & Ivanova, 2013; Kooij et al., 2004; Schweickert, Strober, 
& Moskowitz, 1997; Sokol et al., 1999), FDA approval was based on the findings of three clinical 
trials including an eleven-week Phase II proof-of-concept, placebo-controlled study and two 
twelve-week Phase III placebo-controlled studies (Citrome, 2015; McElroy et al., 2015). Phase II 
tested doses of 30mg, 50mg, and 70mg per day and phase III compared doses of 50mg and 
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70mg per day with placebo controls. The trials found that both 50mg and 70mg but not 30mg 
per day resulted in reduced binge eating episodes per week. Phase III effect sizes ranged from 
0.83 to 0.97 (Citrome, 2015; McElroy et al., 2015). Phase III reported that 42.2% within the 
50mg per day group and 50% in the 70mg per day group achieved binge eating cessation, 
compared to 21.3% in the placebo group (McElroy et al., 2015). Conclusions stated that short-
term treatment with Vyvanse could produce therapeutic effects for BED (Citrome, 2015). 
While these medications may help alleviate binging episodes, the long-term impact of 
psychostimulant use among ED patients as well as the impact on diverse groups is unclear. The 
majority of trial participants were white and female. Moreover, anyone with comorbid illnesses 
was excluded (McElroy et al., 2015), which is a particularly noteworthy limitation given the high 
rates of comorbidities with EDs. The appetite-suppressing side effect was noted as requiring 
further consideration (Citrome, 2015). To date, the longest trial lasted twelve weeks. A longer 
fifty-two week open-label trial is underway, although results are not yet available (Citrome, 
2015). Despite the lack of long-term data, and information related to diverse groups, as well as 
those with comorbidities, Vyvanse is now approved and available to patients with BED. In 
support of psychostimulant treatment options, a review of the available clinical trial data 
suggested that while cognitive behavioral and interpersonal therapy may be effective for BED, 
access to these options might be limited due to availability and cost (Citrome, 2015). 
Increased understanding of the long-term consequences of using psychostimulants to 
treat EDs is crucial based on the potential for addiction and physical health consequences. First, 
psychostimulants are associated with heart issues such as increased blood pressure; this risk 
may already be elevated in these patients due to the comorbid obesity (McElroy et al., 2015; 
Striegel-Moore & Franko, 2003). Secondly, the medications are addictive (Farber, 2010). This is 
of increased concern in the subset of patients as both ADHD and EDs are associated with 
addiction (Biederman et al., 1999; Biederman et al., 2010; Hudson et al., 2007; Polanczyk & 
Rohde, 2007). However, it has also been noted that the side effect of decreased appetite may 
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diminish overtime, reducing risk of abuse for weight loss purposes (Keshen & Ivanova, 2013). 
Based on the potential for abuse for the purposes of weight loss (Farber, 2010), and the unclear 
long term effects, there is a need for further investigation of how these medications specifically 
impact patients with comorbid ADHD/ED (Keshen & Ivanova, 2013). At the very least, until 
longitudinal investigations have been conducted, increase caution, monitoring, and follow up 
may be important among patients using psychostimulants to treat BED. 
 
Implications for Prevention of Psychostimulant Abuse 
  There is a concern for the potential of abuse of psychostimulants due to its addictive 
nature and its potential for cognitive enhancement and weight loss (Farber, 2010). The 
medications may also lead to subsequence substance abuse problems (Davis et al., 2015). 
  Evident suggest that psychostimulant abuse is a widespread and growing public health 
issue. Rates of psychostimulant abuse among grade school and high school students range 
from 5% to 9% and 5% to 35% among college students (Low & Gendaszek, 2002; Rabiner et 
al., 2009; Varga, 2012; Wilens et al., 2008). Ritalin is a common psychostimulant used to treat 
ADHD (National Institute of Mental Health, 2008). Over 90% of the all Ritalin worldwide is 
prescribed and consumed within the United Stated (Koch, 1999). Moreover, many adolescents 
lack the knowledge of the potential negative health consequences of psychostimulant abuse 
(White, Becker-Blease, & Grace-Bishop, 2006). Supporting this lack of awareness, the number 
of calls to poison control due to psychostimulant abuse among adolescents age thirteen to 
nineteen rose by 76% between 1998 and 2005 (Setlik, Bond, & Ho, 2009). 
  While the most common motivation for abuse is enhanced academic or cognitive 
performance, motives also include “getting high” and weight loss. Several studies that 
investigated motives for abuse found a small proportion of women who reported abuse for the 
purposes of weight loss (Rabiner et al., 2009; Varga, 2012). One study reported that 51.7% of 
psychostimulant abusers endorse weight loss as a motivation for the abuse (Tolleson-Rinehart, 
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Massie, & Hughes, 2007). 
  The risk for abuse may be elevated in adolescents with comorbid ADHD/ ED.  An 
improved understanding of the impact of medication and long-term consequences of these 
medications is needed specifically among this subset of patients. Efforts to decrease 
psychostimulant abuse through alternate treatment plans and secondary prevention through 
monitoring medication use among children and adolescents with ADHD who are at-risk for co-
occurring EDs may significantly impact the risk for prescription medication abuse. 
 
Implications for Obesity Prevention and Treatment 
 ADHD and binge eating are linked to obesity (Cortese et al., 2007; Davis et al., 2006; 
Nazar et al., 2008). ADHD is positively correlated with overeating, depressive, and binge eating, 
which are subsequently positively associated with BMI (Davis et al., 2006). Specifically, 
individuals with ADHD might fail to plan meals and meal plans, skip meals due to distractions, or 
have difficulty maintaining intentions to moderate food intake (Pagoto et al., 2009). Most 
importantly, the presence of both disorders impacts the likelihood of weight loss success. Both 
ADHD and binge eating are associated with less weight loss success, poor weight loss 
maintenance, and difficulties with compliance in bariatric surgery follow-up (Alfonsson, Parling, 
& Ghaderi, 2012; Linde et al., 2004; Nicolau et al., 2013). With as many as 61% of patients 
seeking treatment for obesity having signs of ADHD, treating the ADHD first could lead to 
weight loss and decreased need for surgery (Levy, Fleming, & Klar, 2009; Nicolau et al., 2013). 
One study of obese patients with newly diagnosed ADHD compared patients that began 
pharmacotherapy for the ADHD to those that did not accept ADHD treatment. After an average 
of 466 days of continuous ADHD treatment, patients being treated for ADHD lost an average of 
12.36% of their initial weight while the control patients gained an average of 2.78% (Levy et al., 
2009). A similar investigation was conducted in Canada and found that patients that accessed 
ADHD medication treatment lose an average of 10.35% of their initial weight and those that did 
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not accept treatment gained 7.03% (Gruss, Mueller, Horbach, Martin, & Zwaan, 2012). This 
suggests that obese patients should be screened for comorbid ADHD/binge eating and patient 
specific treatment plans focused on the ADHD/ED should be used to reduce the burden of 
obesity among this subset (Levy et al., 2009). Additionally, vomiting is common among patients 
post-surgery, however among a sample of post-surgery patients, 60% reported post-op vomiting 
with 12% admitting to vomiting with the goal of losing weight (de Zwaan et al., 2010). This 
suggests that issues related to ADHD and EDs among these patients needs to be monitored 
post-surgery as well as screened prior to surgery (de Zwaan et al., 2010). However, it has been 
found that the Eating Disorder Examination Questionnaire (EDEQ) does not work the same way 
among bariatric surgery patients (Hrabosky et al., 2008). Exploratory and confirmatory factor 
analysis among bariatric patients found a different factor pattern than the original EDEQ 
(Hrabosky et al., 2008). Additional research is needed to determine or develop the best 
screening tool for both EDs as well as comorbid ADHD/EDs among this population. 
As obesity is associated with a wide range of physical health issues and excess medical 
costs (Hammond & Levine, 2010; Wilfley et al., 2003), reducing the burden of comorbid ADHD 
and EDs may indirectly help reduce the overall burden of obesity, which can have significant 
implications for all aspects of life. The prevention and treatment of obesity among children and 
adolescents with comorbid ADHD/ED could be focused specifically on the underlying 
mechanisms of the comorbidity. Specifically, inhibitory control could be a possible treatment 
target that would both prevent and treat obesity (Reinblatt et al., 2015). 
 
Support for Care Integration 
 A better understanding of the ADHD/ED comorbidity has the potential to impact many 
fields including adolescent behavioral health, general pediatric practices, ED prevention, and 
obesity prevention and treatment. Beyond the implications described above, the ADHD/ED 
comorbidity could impact the integration of physical and mental healthcare. There has been 
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recent widespread recognition of potential positive implications of integrating care (CDC, 2011). 
This integration could be essential to overall health, as it would focus on a holistic approach to 
health (Nardone et al., 2014). A holistic approach to care might improve all aspects of treatment 
for children and adolescents with co-occurring ADHD, EDs, and obesity, due to the multiple, 
complex, and interacting underlying mechanisms. The integrated approach could also have 
implications for the entire family by decreasing the mental and financial burden commonly 
associated with caring for a child with a mental illness (Bazelon Center for Mental Health Law, 
n.d.). In general, getting treatment for a child’s physical health condition is easier than treatment 
for a psychological condition (Glanz & Bishop, 2010). This has led to many issues related to 
access and coverage in children’s mental health systems. However, due to the fact that ADHD 
is commonly treated in a primary care setting, training pediatric healthcare providers to identify, 
monitor, and treat EDs would promote care integration of ADHD, EDs, and obesity, ultimately 
providing improved holistic care, increased provider competence, and decreased burden for 
both the child or adolescent and the entire family. 
 
Conclusion 
 The comorbidity of ADHD and EDs may have several negative consequences to overall 
health and wellbeing. A lack of understanding of the disorder and difficulties treating both 
disorders in fragmented healthcare systems may lead to continued difficulties for the subset of 
patients with this comorbidity. Nonetheless, there is a potential for many types of prevention and 
improved treatment that could greatly impact the quality of life and burden of mental illness 
related to the comorbidity. However, in order to capitalize on these opportunities, a significant 
amount of research is still needed. This research should include investigations of additional 
underlying mechanisms, confirmation through primary data collection, advanced statistical 
techniques to identify multiple combinations of factors, exploration of male-specific 
determinants, and direct gender comparisons. Ultimately, research could lead to the 
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development of improved prevention and treatment that would improve the quality of life for 
anyone with comorbid ADHD/ EDs and decrease the prevalence of both EDs and obesity.
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Appendix A: Confirmatory Factor Analysis of ADHD Symptoms 
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Figure A2. Confirmatory Factor Analysis of ADHD Symptoms among Males 
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Appendix B: Confirmatory Factor Analysis of ED Symptoms 
 
Figure B1. Confirmatory Factor Analysis of ED Symptoms among Females 
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Figure B2. Confirmatory Factor Analysis of ED Symptoms among Males 
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Appendix C: Confirmatory Factor Analysis of Family Support Scale 
 
Figure C1. Confirmatory Factor Analysis of Family Support Scale among Females 
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Figure C2. Confirmatory Factor Analysis of Family Support Scale among Males 
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Appendix D: Confirmatory Factor Analysis of Social Support Scale 
 
Figure D1. Confirmatory Factor Analysis of Social Support Scale among Females 
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Figure D2. Confirmatory Factor Analysis of Social Support Scale among Males 
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Appendix E: Confirmatory Factor Analysis of Personality Scales 
 
Figure E1. Confirmatory Factor Analysis of Personality Scales among Females 
 
 
  
 129
Figure E2. Confirmatory Factor Analysis of Personality Scales among Males 
 
 
  
 130
Appendix F: Confirmatory Factor Analysis of Cognitive Control Scale 
 
Figure F1. Confirmatory Factor Analysis of Cognitive Control Scale among Females 
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Figure F2. Confirmatory Factor Analysis of Cognitive Control Scale among Males 	  	  
